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ABSTRACT
QUANTIFYING THE IMPACT OF ALTERED HEMODYNAMICS AND
VASCULAR BIOMECHANICS TO CHANGES IN STRUCTURE AND FUNCTION
IN NATIVE AND CORRECTED AORTIC COARCTATION

Arjun R. Menon
Marquette University, 2012

Coarctation of the aorta (CoA) is associated with substantial cardiovascular
morbidities despite successful treatment through surgical or catheter-based intervention.
Although specific mechanisms leading to these morbidities remain elusive, abnormal
hemodynamics and vascular biomechanics are implicated. We used a novel animal model
that facilitates quantification of CoA-induced hemodynamic and vascular biomechanics
alterations and their impact on vascular structure and function, independent of genetic or
confounding factors. Rabbits underwent thoracic CoA at 10 weeks of age (~9 human
years) to induce a 20 mmHg blood pressure (BP) gradient using permanent or dissolvable
suture thereby replicating untreated and corrected CoA. Computational fluid dynamics
(CFD) was performed using subject-specific imaging and BP data at 32 weeks to quantify
velocity, strain, and wall shear stress (WSS). Vascular structure and function were
evaluated at proximal and distal locations by histology, immunohistochemistry, and
myograph analysis.
Results revealed proximal systolic and mean BP was elevated in CoA compared
to corrected and control rabbits leading to vascular remodeling, endothelial dysfunction
proximally and distally, and increased stiffness and reduced active force response
proximally. Corrected rabbits had reduced but significant medial thickening, endothelial
dysfunction, and stiffening limited to the proximal region despite 12 weeks of alleviated
systolic and mean BP (~4 human years) after the suture dissolved. Proximal arteries of
CoA and corrected groups demonstrated increased non-muscle myosin expression and
decreased myosin heavy chain expression, and this dedifferentiation may influence
vascular remodeling and aortic stiffening. CFD analysis of untreated CoA rabbits
demonstrated significantly reduced WSS proximal to CoA and markedly elevated WSS
distally due to the presence of a stenotic velocity jet. Results from corrected rabbits
indicate the velocity jet may have persistent effects on hemodynamics, as WSS remained
significantly reduced. These hemodynamic and morphological observations are
consistent with alterations in human patients.
Using these coupled imaging and experimental results, we may determine
changes in structure and function specific to CoA and correction and how they are
influenced by hemodynamics and vascular biomechanics. We are now poised to augment
clinical treatment of CoA through several methods, including investigation of specific
cellular mechanisms causing morbidity in CoA and the development of therapies to
improve endothelial function and restore vascular stiffness.
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CHAPTER 1: SPECIFIC AIMS

2
Coarctation of the aorta (CoA) is a congenital heart defect characterized by a
severe stenosis in the proximal descending thoracic aorta. It currently represents 8-11%
of congenital defects, affecting 3,000 to 4,000 newborns annually in the United States
[7]. Surgical intervention, most commonly through resection with end-to-end
anastomosis, can alleviate the blood pressure (BP) gradient and post-operative survival
outcomes have improved dramatically as a result. However long-term evaluations of
surgically repaired patients reveal a decreased life expectancy due to substantial residual
morbidity in the form of early-onset coronary artery disease, hypertension, and aneurysm
formation [8, 9], challenging the notion of CoA as a simple disease. While specific
mechanisms remain elusive, early research from O’Rourke and Cartmill suggested that
nearly all morbidity can be explained on the basis of altered hemodynamics and vascular
biomechanics [10] in the thoracic aorta and its branches.
Computational fluid dynamics (CFD) is a simulation tool that enables detailed
spatiotemporal quantification of mechanical forces based on magnetic resonance imaging
(MRI) and BP data. Using CFD in concert with imaging data, a patient-specific vascular
region of interest can be modeled for investigation of cardiovascular disease
susceptibility based on regional and local alterations in hemodynamics and vascular
biomechanics. Studies by our group and others [11-14] have shown alterations in
hemodynamic indices and blood flow patterns in the thoracic aorta occurring in patients
following CoA repair as compared to healthy age-matched controls. Importantly, changes
in BP and wall shear stress (WSS) in conduit vessels may influence structural
remodeling, active and resting vascular contractility, and vasorelaxation in a coordinated
manner [15-17]. Collectively these studies suggest that CoA may impart changes in
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hemodynamics and vascular biomechanics that are not fully corrected with surgical
repair. These alterations may influence the structure and function of the associated
vasculature, thereby increasing the likelihood of residual cardiovascular morbidities.
The current investigation used an established experimental model that mimics
clinical CoA as well as morphology observed after end-to-end anastomosis repair to test
the hypothesis that despite alleviating deleterious BP gradients and vascular morphology
present in CoA, altered indices of hemodynamics and biomechanics persist, leading to
sites of vascular remodeling, endothelial dysfunction, and altered contractility. This
hypothesis was tested using the following specific aims:

SPECIFIC AIM #1: Quantify alterations in hemodynamic and vascular biomechanics
indices including blood flow velocity, WSS, oscillatory shear index (OSI), and cyclic
strain as surrogates of morbidity in a clinically representative rabbit model of aortic
coarctation and repair.
Approach:

Randomly assign 10 week old, ~1 kg rabbits (~equivalent to 9 human

years) to one of three experimental groups: 1:CoA with silk suture replicating untreated
coarctation (CoA); 2: CoA with Vicryl suture that dissolves over 8-10 weeks to mimic
surgical resection and end-to-end anastomosis (corrected); and 3: non-surgical control.
All rabbits then undergo MRI at 32 weeks of age to obtain vascular anatomy and phase
contrast (PC-MRI) flow data for use with CFD simulations. Intravascular BP
measurements are then collected above and below the coarctation region and CFD
simulations are conducted. Hemodynamic and vascular biomechanics indices of interest
mentioned above are then quantified from converged CFD simulation results.
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SPECIFIC AIM #2:

Compare structural changes in the arterial wall accompanying

coarctation-induced alterations in hemodynamics and vascular biomechanics using
histological techniques.
Approach:

Medial thickness and remodeling are quantified using arterial segments

excised from the carotid artery, thoracic aorta proximal to coarctation, descending
thoracic aorta distal to coarctation, and femoral artery using established histological and
immunohistochemistry techniques and compared to spatial distributions of WSS, OSI,
BP, and cyclic strain from CFD simulations.

SPECIFIC AIM #3:

Quantify the endothelium-dependent and contractile responses to

agents using established myograph techniques for arterial segments in regions of altered
hemodynamics and vascular biomechanics proximal and distal to experimental
coarctation as compared to control rabbits.
Approach:

Functional vascular response to contractile and vasorelaxation agonists are

quantified for arterial segments excised from the regions from the thoracic aorta
mentioned in Aim 2 using established myograph techniques and compared to spatial
distributions of BP, as well as WSS, OSI, and cyclic strain from CFD simulations.
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CHAPTER 2: BACKGROUND

6

2.1 Coarctation of the aorta
Congenital heart disease is a major health problem, affecting more than 30,000
infants per year in the United States alone. CoA is currently the second most common
congenital defect, occurring in 8-12% of these births annually [18], and more commonly
in males than females (4:1). The disease is characterized by a severe stenosis in the
proximal descending thoracic aorta (Figure 1). CoA most commonly occurs distal to the
left subclavian artery and opposite the ductus arteriosus, a vessel present during fetal
development containing smooth muscle cells which are thought to cause partial ductal
closure immediately after birth [19].

Figure 1. Transverse view of untreated aortic coarctation, with a stenosis present in the proximal
descending thoracic aorta (white arrow). AoA = Ascending aortic arch, dA = descending aorta,
PT = pulmonary trunk. (Adapted from Leschka et al, [1])

CoA is often associated with other cardiovascular defects including ventricular
septal defect, aortic arch hypoplasia, hypoplastic left heart syndrome, and most
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commonly bicuspid aortic valve [20]. In addition 30% of patients diagnosed with the
chromosomal disorder Turner’s syndrome also present with CoA [21].
Together CoA and its associated abnormalities impede the conduit and cushioning
functions of aorta, which respectively include the large arteries that rapidly deliver
oxygenated blood for distribution to tissues and organs with minimal pressure loss, as
well as the pronounced capacitance that is the hallmark of the thoracic aorta and contains
approximately 60% of the total arterial capacitance [4]. While these changes may have
several consequences, the most commonly reported involves the development of a BP
gradient across the CoA, an elevation in pulse BP proximally, and a drop in pulse BP
distal to the CoA. As such, putative clinical guidelines for treatment of CoA includes a
mean BP gradient of ≥20 mmHg between the upper and lower extremities [22]. The
source of symptoms of CoA are unclear, but often associated with increased BP in the
proximal vasculature and are may include hypertension, shortness of breath, exercise
fatigue, headaches, nosebleeds, and leg pains associated with claudication [23].

2.2 Motivation: Residual morbidity despite successful surgical repair
Treatments for coarctation have developed considerably over the years and
include both catheter-based and surgical approaches. Recent developments in catheterbased techniques include the use of balloon dilation for CoA as early as 1982 and stent
implantation in the early 1990s [24, 25]. While these catheter-based techniques offer
reduced hospitalization time and costs, the need for re-intervention and increased
likelihood for re-coarctation due to somatic growth associated with these techniques are
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potential limitations to their use in children [26]. In contrast, surgical repair of CoA was
first performed in 1944 and remains the treatment of choice in children <1 year old [27,
28]. Evidence of long-term aneurysm risks (as high as 23%) following techniques
involving synthetic patch aortoplasty lead to the preference of resection and end-to-end
anastomosis techniques and aneurysm risk has decreased to approximately 5-8% as a
result [27], with aneurysm risk in the general population reported to be between 1.4-4.0%
[29]. This procedure involves excision of the coarctation using an incision along the
underside of the aortic arch and posterior wall of the descending aorta. Aortic tissue is
then sutured, or anastomosed, together [30-32] (Figure 2). However a high incidence
(24-41%) of recoarctation is reported [33].

Figure 2. Schematic of resection and end-to-end anastomosis repair. The region of the
coarctation is resected and the vessel ends are joined using circumferential sutures perpendicular
to the flow domain. (Adapted from Thumbnail Guide to Congenital Heart Disease [2])

Subsequent research involving this intervention found recoarctation rates were reduced
from 41% to 3.6 % when a longer anastomosis is used. This method, known as extended
end-to-end anastomosis (Figure 3), uses a suture line beveled (oblique) to the primary
direction of blood flow and simultaneously addresses posterior arch hypoplasia [32].
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Figure 3. Depiction of extended end-to-end anastomosis repair of CoA. This technique reduces
the chance of re-coarctation by using a larger region of anastomosis than traditional end-to-end
anastomosis repair. (Adapted from Gargiulo et al, 2007 [3])

Despite postoperative BP restoration, studies continue to show significant residual
morbidity including coronary artery disease, resting or exercise-induced hypertension,
cerebral aneurysms, and stroke in patients after repair by any means. The natural history
of CoA documented in the literature therefore suggests life expectancy are decades less
than that of the average population despite treatment, challenging the notion of CoA as a
simple pathology [8, 9].

2.3 The possible influence of hemodynamic and vascular biomechanics indices on
CoA morbidity
Mechanical forces influence the development and progression of cardiovascular
disease. Alterations in arterial structure are common in vascular diseases and are thought
to occur primarily by vascular remodeling, defined as any change in the vessel geometry
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in response to hemodynamic and vascular biomechanical stimuli [34, 35].
Hemodynamics is defined by forces that govern blood flow and include blood pressure
and derivatives of velocity. Biomechanics concerns the effects produced by internal and
external forces acting on the vascular system (in particular structure and function). For
the purposes of this study, vascular biomechanics include parameters of cyclic strain,
medial thickness, and vascular relaxation and constriction. While the source of these
structural alterations are not fully understood, research illustrating the role of WSS in
endothelial nitric oxide (NO) release in vasodilatation and modulation of wall thickness
through cell turnover (proliferation and apoptosis) has elucidated the role of WSS in
myogenic regulation [15, 16, 36]. Vessels respond to an increase in WSS associated with
concomitant increases in blood flow by increasing production of NO which subsequently
dilates the vessel, increasing lumen size and thus returning WSS and eventually NO
production back to a normal and preferred range of operating values. This homeostatic
response of WSS is essential for certain processes including exercise, where local
increases in oxygen demand occur which require increased blood flow [37]. However, if
WSS alterations are sustained, changes in arterial medial thickness can occur through cell
turnover and reorganization in the dilated (or constricted, in the case of reduced WSS)
state such that the arterial wall becomes re-established at a diameter and thickness that
differs from that associated with the preferred range of operating values. Although blood
flow and thus WSS are returned to near normal values in cases of corrected CoA, local
alterations persist [14] and may cause persistent alterations to vascular structure and
function associated with CoA morbidity [36].
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This homeostatic response can be accordingly applied to changes in tensile stress,
wherein arteries with elastic properties respond to changes in BP by altering luminal
radius in a manner that maintains wall tensile stress at normal levels. Assuming BP
returns to normal soon thereafter, wall tensile stress is reduced and the vessel regains its
original caliber. If the BP increase is sustained however, compensatory vascular
remodeling may occur to increase medial thickness in the dilated state, thus restoring
tensile stress to its preferred homeostatic level. This may serve to reset vessel caliber or
thickness at a level where indices of vascular structure, biomechanics, and function are
altered and cannot return to their prior functional levels despite restoration of BP due to
changes in vascular smooth muscle content and organization.
The specific mechanisms associated with altered arterial wall structure and
function as a result of sustained changes to mechanical forces are not fully defined and
may be due to both cellular and acellular changes in the associated vasculature. Acellular
changes causing increased wall stiffness, medial thickness, and altered expression of
contractile and structural proteins can limit changes in BP by offsetting the smooth
muscle response. These changes may impart the vasculature with a high residual wall
stress which serves to reduce relaxation capability and exaggerate exercise induced
increases in BP. Alternatively, mechanisms of morbidity may be rooted in cellular
mechanisms involving impairment of vasodilation through endothelial NO release, or
reactive molecules present due to the applied hemodynamic/tensile stresses [38, 39].
Together these findings suggest that sustained alterations to hemodynamic and vascular
biomechanics indices as a result of CoA may cause altered structural reorganization along
with mechanical forces that are not fully alleviated by the removal of the CoA stenosis.
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These alterations may contribute to the high rates of residual morbidity observed
following CoA repair. Table 1 shows an illustration of how alterations to these
parameters of hemodynamics and biomechanics may relate to an increased potential of
morbidity.

Table 1. Description of how alterations to parameters of hemodynamic and vascular
biomechanics may serve as surrogates for the potential of morbidity and mortality
reflective of the major causes of death in post-repair CoA patients.

2.4 Sustained hemodynamic alterations influence vascular function
In addition to relaxation previously discussed, endothelial cells (ECs) also
mediate inflammatory and thrombogenic responses through the selective release of
coagulants, adhesion molecules, and cytokines [15, 40, 41]. Dynamic physiologic
response of the endothelium is essential. However, persistent or deleterious changes in
hemodynamics and vascular biomechanics can lead to a state of impaired endothelial
release of NO and vasodilation, known as “endothelial dysfunction”. Endothelial
dysfunction has been associated in the development of atherosclerosis and thrombosis in
addition to reduced vasodilatory capacity [42], but studies have only recently identified
specific mechanisms in this process [40, 43, 44]. As a result, endothelial dysfunction may
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connect altered functional experimental results in pathophysiological conditions with
appropriate surrogates for morbidity. Early-onset coronary artery disease in particular has
been associated with endothelial dysfunction [27], and thus observation of dysfunction in
untreated and corrected CoA may suggest an increased risk of morbidity in these groups.
Sustained alterations in WSS and BP may also serve to alter vascular contractility
in a coordinated manner. The classic myogenic response involves the reduction of vessel
diameter in response to an increase in BP, which is thought to be caused by an increase in
cyclic stretch on smooth muscle cells (SMCs). The relative contributions of active and
resting force on the regulation of arterial diameter depend on the dynamic interaction
between resting tension, diameter, and the magnitude of active tension [45]. It is likely
that similar mechanisms are involved in the vascular response to deleterious increases in
BP. As previously discussed, the arterial vasculature is believed to maintain wall tensile
stress homeostasis by structural and regulatory changes, and these may have direct
consequences on the resting and active contractile components of smooth muscle.
Changes in vessel stiffness due to hypertension occur primarily as a result of increased
pulse BP and have been directly associated with increased risk of coronary artery disease
and atherosclerosis [46-49]. Active force components may reflect deleterious changes as
well [50, 51] as changes in medial thickness, extracellular matrix deposition not
discussed in detail here, and endothelial function may result in altered active force which
is indicative of atherogenic changes in the conduit vessels.
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2.5 Review of abnormal hemodynamics and vascular biomechanics in CoA
literature
Surgical correction of CoA suggests that removal of the stenosis should alleviate
hypertension proximal to the site. However studies as early as 1971 [10, 52, 53] applied
the theory of vascular impedance and wave reflection to describe the effect that large
artery diseases such as CoA have on the cushioning function (i.e. capacitance) of the
arterial system. Vascular input impedance is defined as pulsatile resistance, ratio of
oscillatory BP and flow, at any particular region of the arterial vasculature. Input
impedance completely describes the arterial system and relevant physiological
parameters of capacitance, systemic vascular resistance, and characteristic impedance can
be derived from its spectra [54, 55] (Figure 4). Arterial capacitance is classically defined
as the relationship between blood volume in a segment of vasculature and the pressure
distending on the vascular walls, and thus provides an index of elasticity of the large
arteries such as the thoracic aorta, an important risk factor for cardiovascular disease.
Systemic resistance, or total vascular resistance, refers to the resistance to blood flow
offered by the entire systemic vasculature and is primarily determined by arterioles [54].
Characteristic impedance represents the resistance, compliance, and inertance of the
proximal artery of interest.
CoA causes a marked reduction in proximal aortic compliance, leading to
increased pulse and systolic BP during rest. These alterations may affect diastolic BP and
thus coronary artery perfusion providing a possible explanation for the high rates of heart
failure seen in these patients.
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Figure 4. Representative input impedance spectra with relevant physiological indices labeled
(left). Patient data from control and coarctation subjects reveal differences due to coarctation
observable on the impedance spectra (right).Total vascular resistance and characteristic
impedance are increased in CoA, highlighted by circles and dash-dotted lines respectively.
Dashed lines indicate reduced compliance in CoA through a less negative impedance modulus
slope. (Adapted from Nichols and O’Rourke, 1971, [4]).

To counteract the reduced blood flow to the descending aorta in cases of untreated
CoA, it is common for collateral vessels to develop [56]. Collateral vessels commonly
originate from the left subclavian artery and create anastomoses to the intercostal
circulation, thus restoring conduit blood flow function. The long and tortuous nature of
collateral vessels unfortunately still impedes the cardiovascular system's ability to
transmit pressure pulses, thus impairing the cushioning function of the thoracic aorta.
Recently, studies using multidirectional flow analysis for detailed investigation of
hemodynamics in the human thoracic aorta [57] found healthy young adults demonstrate
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low WSS and elevated OSI occurring in a rotating pattern progressing down the
descending aorta. A subsequent study of middle-aged adults with preexisting plaques had
similar WSS and OSI patterns which correlated with areas of atherosclerotic plaque. CoA
patients following end-to-end anastomosis repair demonstrate localized alterations to
WSS compared to age-matched controls, and these findings are in agreement with 4D
MRI flow studies illustrating altered blood flow patterns in the aorta associated with
vascular remodeling and aneurysm risk following coarctation repair [58, 59].
Together, these observations were able to establish a connection to altered
hemodynamics and vascular biomechanics which may influence morbidity in a manner
reflective of the major causes of death observed in treated CoA patients. Application of
these observations to the current status of treatment suggests that surgical repair of CoA
may not address flow disturbances and mechanical stresses in the aorta that may
influence residual morbidity in these patients.

2.6 Structural alterations following CoA correction
To date several clinical studies have investigated the structure of arterial conduit
vessels using post-repair CoA patients to determine possible factors of residual morbidity
[60-62]. Using non-invasive B-mode ultrasound imaging, arterial intimal-medial
thickness (IMT) and subsequent changes can be determined at important locations in the
vasculature. IMT is influenced by local hemodynamics and vascular biomechanic indices
and has been used as a surrogate end point for cardiovascular disease risk [63],
particularly atherosclerosis. Prospective studies have shown that an increase in IMT is
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associated with increased relative risk of heart failure, while decreased IMT is associated
with a decreased risk. Clinical evaluations of IMT were performed in carotid and femoral
arteries of postcoarctectomy patients and compared to age-matched, normotensive,
healthy volunteers [60]. Interestingly, results demonstrated IMT was increased in young
patients (ages 24-30) after successful repair of CoA compared to controls, particularly in
the carotid arteries. While early surgical intervention (defined as <1 year) was
demonstrated to have a beneficial effect on the distal vasculature, carotid arteries still
demonstrated increased IMT despite repair as early as neonatal age. These results
suggested for the first time that structural abnormalities are present despite successful
surgical intervention in CoA and may indicate an increased risk of cardiovascular
complications. The specific mechanisms causing these structural alterations are not
precisely known, but thought to be a result of either the damaging effects of elevated
arterial BP in the proximal arteries or an innate developmental defect present in the CoA
pathology [62, 64].

2.7 Functional alterations following CoA correction
Expanding on these findings of altered structure, several studies [60, 65, 66]
investigated functional properties of the conduit arteries in post-repair CoA patients using
forearm blood flow measured through gauge-strain plethysmography. Briefly, the change
in diameter of the brachial artery was determined after producing a brief ischemia in the
forearm through a suprasystolic BP cuff. Deflation of the BP cuff causes reactive
hyperemia which produces a WSS stimulus inducing endothelial release of NO and
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vasodilation [67]. While it does not provide an exact measure of functionality, this
approach known as flow-mediated dilatation has been established to reflect endothelial
function of the brachial artery and correlates with coronary endothelial function [68].
Results from the clinical evaluations revealed that despite no differences in systolic BP,
endothelial vasodilatory function was impaired in repaired patients (ages 29-33) at 10-15
year follow up compared to healthy controls, and that the severity of dysfunction was
related to age at surgery [65, 69]. While endothelial dysfunction provides evidence of
altered vasodilatory properties, it also indicates a compromised anti-inflammatory
capacity of the endothelium. This was subsequently confirmed in follow up studies of
post-repair CoA patients [70], and further supports a possible explanation for the high
incidence of coronary artery disease in these patients.
Together these findings suggest that despite alleviation of the BP gradient and
vessel geometry, post-repair normotensive patients show morphological and functional
changes in the conduit vasculature that may influence and predict future morbidities
leading to reduced life expectancy.

2.8 Computational Fluid Dynamics
Recent advancements in computational modeling have led to the implementation
of CFD as a tool to investigate altered hemodynamics resulting from vascular diseases.
Previous CFD studies were often conducted assuming a constant BP or velocity profile at
the vessel outlets, but arterial blood flow is strongly influenced by the distal arteriolar
bed. The methods used for the current investigation therefore allow accurate

19
representation of the systemic vasculature by including an estimate of the time-varying
resistance that occurs in vivo through the use of 3-element Windkessel models at the
computational domain outlets [71]. Subject-specific data including BP and distribution of
flow to the branch arteries of the aorta are used to determine these outlet boundary
conditions, resulting in CFD models with physiologically representative flow and BP
distributions. As mentioned in the introduction, several hemodynamic indices are of
particular interest when studying morbidity in the setting of CoA including blood flow
velocity, time-averaged wall shear stress (TAWSS), and OSI. The analysis of vascular
biomechanics includes indices of cyclic strain, distensibility, and stiffness. The detailed
calculations associated with these indices are discussed in more detail in the methods
section in chapter 3.
Clinical imaging data and novel computational modeling tools may be combined
for detailed analysis of CoA induced alterations to hemodynamics and vascular
biomechanics using CFD. While CFD studies on human patients with CoA are still in
their infancy, work in our laboratory has identified localized differences in hemodynamic
indices in corrected CoA using CFD which are consistent with 3D and 4D MRI imaging
studies detailing velocity distributions as mentioned previously [57, 72, 73]. However the
direct link between altered indices and changes in the vasculature is difficult to establish
due to the limited number and heterogeneity of patients at any given center.
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2.9 Clinical significance
An in vivo model was used to quantify hemodynamic and vascular biomechanics
indices seen in untreated and corrected CoA, and subsequently their impact on vascular
histology and function. Furthermore, it aimed to reproduce changes in these indices
observed in untreated CoA distinctly from those occurring after correction of BP and
morphology in a manner similar to resection and end-to-end anastomosis, currently the
most common method of intervention in congenital CoA [3, 32]. The collective results
may improve our clinical understanding of the substantial morbidity present in CoA
patients despite successful repair. Identification of changes in hemodynamics, vascular
biomechanics, structure, and function caused specifically by untreated CoA and
correction may augment current clinical intervention techniques for CoA, which currently
does not consider these phenomena. Identification of specific changes caused specifically
by CoA and correction may allow optimization of surgical techniques such that indices of
hemodynamics in post-correction CoA patients are restored as closely as possible to those
of healthy patients. In addition, implementation of the current model may allow future
studies to identify specific cellular mechanisms caused by altered hemodynamics and
vascular biomechanics which directly relate to deleterious structural and functional
changes in corrected CoA. Identification of specific cellular pathways in CoA
pathophysiology increases the feasibility of applying appropriate drugs (inhibitors) which
may alleviate cardiovascular morbidities, thus dramatically improving patient outcomes
in CoA.
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CHAPTER 3: METHODS COMMON TO ALL AIMS
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3.1 Experimental protocol
All experimental procedures were approved by the Animal Care and Use
Committee of Marquette University and the Medical College of Wisconsin (IACUC #:
Marquette AR-223, MCW AUA0001175). In addition, all conformed to the “Guiding
Principles in the Care and Use of Animals” of the American Physiological Society and
the Guide for the Care and Use of Laboratory Animals. Following a 72 hour acclimation
period, male New Zealand white rabbits ~10 weeks old were randomly assigned to
undergo either descending thoracic aortic coarctation with Vicryl (dissolvable) suture
(n=7, corrected group), coarctation with silk suture (permanent; n=7, CoA group), or
non-operation control (n=7, control group). Rabbits in surgical groups were given 40
mg/kg of ketamine and 5 mg/kg of xylazine intramuscularly, and underwent endotracheal
intubation, where anesthesia is maintained by 1-2% isofluroane administered through
ventilator (Harvard Apparatus, Holliston, Massachusetts). The antibiotic cefazolin (20
mg/kg) was administered at least 1 hour prior to the first incision, and fur above the 3-8th
intercostals spaces was shaved and prepped for sterile surgery using antiseptic solution.
CoA in the mid-descending thoracic aorta was induced through a left thoracotomy
between the 5th and 6th intercostal arteries. Muscular and tissue layers were carefully and
gently navigated to expose the descending proximal thoracic aorta (dAo). 3-0 silk (CoA
group) or Vicryl (corrected group) ligatures were then tied around the aorta against a 16
gauge (1.6 mm) stainless steel wire. Removal of the wire resulted in a CoA of repeatable
and known size causing a 15-30 mmHg BP gradient across the CoA at harvest as verified
by previous research [74, 75]. Notably, “clinical significance” for CoA is commonly
defined as a BP gradient of ≥20 mmHg at rest [22, 76] and thus a gradient of 20 mmHg
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was targeted using this technique. To evacuate the pneumothorax caused by induction of
CoA, a flexible tube was inserted into the pleural cavity, secured by a purse-string suture,
and the chest was closed in layers. Suction was applied to the tube using a syringe and 3way stopcock, and the tube was removed 1.5 hours after surgery when the rabbit was
sternal and no additional air or fluid could be extracted.

3.2 Monitoring
Extensive monitoring was conducted during all experimental procedures using
quantitative criteria with preferred operating ranges for oxygen saturation, heart and
respiratory rate, temperature, mucous membrane color and capillary refill time.
Monitoring was conducted at ten-minute intervals during procedures, as well as for 4-5
hours after surgery and 2-3 hours after the MRI procedures discussed below.
Buprenorphine (0.025 mg/kg SQ) and cefazolin (20 mg/kg SQ) were administered for
postoperative analgesia and antibiotic prophylaxis, respectively, for two days after
surgery. Qualitative criteria such as attitude, appetite, urination, defecation, vomiting and
appearance of the surgical site were recorded along with the clinical measures mentioned
above 2, 3, 5, 10 and 14 days after surgery and periodically thereafter. Furosemide was
also administered for two weeks post-op (4 mg/kg SQ BID) and as needed thereafter to
treat any ensuing respiratory symptoms due to pulmonary edema. Rabbits were provided
with enrichment in 4x8 ft runs.
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3.3 Magnetic Resonance Imaging
Rabbits underwent anatomic and phase contrast MRI for use with CFD modeling
to allow determination of cyclic vascular strain upon reaching adult size at 32-36 weeks.
Rabbits were anesthetized using ketamine (22 mg/kg) and xylazine (2.5 mg/kg) and a
saline filled angiocath IV inserted into the left marginal ear vein for contrast-enhanced
illumination of the thoracic aorta and its branches. Cardiovascular MRI was conducted
with a 3T GE Sigma Excite scanner (GE Healthcare, Waukesha, WI) in the supine,
“head-first” position using a quadrature knee coil and the sequences shown in Table 2.
To ensure adequate anesthesia, an external pulse oximeter (Nonin Medical Inc, Plymouth,
MN) and a core temperature sensor approved for use in the MR environment were
included. Cardiac triggering was obtained by use of a peripheral pulse oximeter attached
to the right ear which provided heart rate. Two doses (0.2 mmol/kg) of gadolinium (Gd;
Omniscan gadodiamide; GE Healthcare, Princeton, NJ) were prepared and loaded into
the distal end of extension tubing that was connected to the angiocath IV. Additional
saline-filled extension tubing was also attached to the IV and an MR-compatible pump
within the scanner room. Rabbits were allowed to breathe freely throughout the imaging
session. Gadolinium-enhanced magnetic resonance angiography (MRA) scans were
performed at an injection rate of 2 ml/sec. Gadolinium dose was limited to 0.2 mmol/kg
based on common usage of animals of similar size. Blood flow information for use with
CFD was acquired using a cardiac-gated, 2D, PC-MRI sequence with through-plane
velocity encoding. PC images were obtained at planes transverse to the ascending aorta
(AscAo), the cervical arteries, the coarctation, and dAo.
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MRA

PC-MRI

Sequence

3D fast GRE

2D fastcard PC

TR/TE/flip angle

6.0 ms/1.7 ms/30 degrees

8.5 ms/1.7 ms/20 degrees

Slice thickness

1.2 mm

3.0 mm

Acquisition matrix (pixels)

256 x 192

256-384 x 224-256

Field of view (cm)

12 x 12

12 x 12

VENC (cm/sec)

-

80-200

Cardiac frames

-
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Table 2. Magnetic resonance imaging parameters utilized for collection of volumetric MRA and
PC-MRI flow imaging data.

3.4 Intravascular blood pressure measurements
After detailed offline analysis of MRI data, rabbits were again anesthetized for
measurement of BP prior to tissue harvest. Proximal and distal aortic BP waveforms were
measured simultaneously and obtained from the same model pressure transducer
(Harvard Apparatus, Holliston, MA) from which waveforms were digitally recorded at
720 Hz using a computer interfaced with an analog-to-digital converter. Transducers
were attached to 5 inch noncompliant fluid-filled catheters. The proximal fluid-filled
catheter was inserted into the common carotid artery and tracked retrogradely to the
aortic arch. The distal fluid-filled catheter was inserted into the femoral artery and
tracked retrogradely to the aortoiliac bifurcation.
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3.5 CFD
3.5.1. Model Creation
The three-dimensional MRA data from each rabbit was used to reconstruct the
vessel geometry and contour of the thoracic vasculature. MRA imaging data was
processed using specialized software to correct for any gradient nonlinearities that can
cause geometric distortions within the imaging volume. Using software that facilitates
volume visualization and conversion of the MRA imaging data into geometrically
representative computer models, CFD representations were created for each subject
imaging set. Briefly, the process of model creation involves finding the centerline path of
each artery, performing segmentations to delineate the arterial wall, connecting these
segments to form a representative model, and discretizing the model using a
commercially available automatic mesh generator. A brief outline of the model creation
process is shown in Figure 5.
2D segmentation techniques were used to build all models, which began at the
level of the aortic sinus and included the ascending, transverse, and descending aorta
terminating at the level of the diaphragm. Head and neck vessels including the right
common carotid (RCCA), right subclavian artery (RSA), left common carotid (LCCA),
and left subclavian artery (LSA) were included in the model. MRA volumetric data
acquired as previously described was visualized for geometric modeling using eFlim
(Merge Healthcare, Milwaukee, WI) software and Simvascular. Volume rendering was
performed in VolView where parameters of visualization were determined and
subsequent .vti files were loaded into Simvascular.
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Vessel centerline paths through regions of interest were manually created through
all arteries included in each CFD model. Spline points were then used to smooth the
centerlines depending on the length and tortuosity of the vessel and paths were saved
using unique identifiers as they act as the basic framework of the 2D model construction.
For all models, 300 spline points were used to generate the path of the thoracic aorta, and
100 spline points were used for the branch vessels. The imaging data was then resampled
in planes perpendicular to the centerline and the vessel lumen was segmented using
manual segmentation techniques to accurately delineate the vessel boundary. All 2D
segments were stored using unique identifiers for each vessel of interest. Segments were
adjusted axially to avoid intersection or artificial shape changes and create geometrically
representative and well defined vessels.
The set of 2D segments delineating the vessel lumen along the centerline path for
each vessel of interest was lofted to form a solid model. Individual vessels were joined
into a single solid model. Branch intersections were blended to create smooth transitions
between vessels reflective of the native physiology. Solid model faces were defined as
inflow, outflow, or wall to prescribe boundary conditions and facilitate analysis of
surface properties. The solid model was then discretized into an isotropic mesh of chosen
edge size [77, 78] before local adaptation of this computational mesh was performed as
described in more detail below.
As detailed above, rabbits in CoA group retained a dramatic stenosis due to
implantation of the CoA with permanent silk suture which resulted in a mean BP gradient
of ~20 mmHg in the thoracic aorta. In order to accurately represent this gradient in the
computational domain, the diameter of the stenosis was delineated from PC-MRI data
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obtained at the location of the CoA. The vessel segment corresponding to the CoA was
then adjusted to match this measured diameter and the measured BP gradient. CoA
models were then subjected to steps typical of a traditional numerical simulation with
mesh adaptation and pulsatile analysis as described below.

Figure 5. Overview of the process used to create CFD models using a 2D model creation process.
Vessel centerlines are created from MRA data, from which vessels of interest are segmented and
lofted to form the model, which is finally discretized into the mesh of chosen edge size.

3.5.2 Inlet boundary conditions
PC-MRI images were obtained orthogonal to the ascending aorta near the aortic
sinus. The vessel lumen was delineated from PC-MRI images using the Simvascular
software package and pixel velocity values within the segmented region were adjusted
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with a second order, spatially dependent baseline correction algorithm to account for
phase errors that result from gradient eddy currents. The corrected velocity was then
integrated over the 2D lumen segmentation to yield an instantaneous flow rate at each of
the 20 PC-MRI images. The ascending aorta waveform was then mapped to the inlet face
of the CFD model using a time-varying parabolic velocity profile (Figure 6).

Figure 6. Representative maximum intensity projections of each experimental group from
MRA data (top). Phase-contrast MRI phase and magnitude data at the ascending aorta
(bottom left) used to calculate inflow waveform (bottom right) for use in CFD
simulations.
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3.5.3 Outflow boundary conditions
In order to create a physiologically relevant CFD model, simulation flow and BP
values were matched to flow waveforms obtained at the RSA, RCCA, LCCA, and LSA
along with measured BP data to prescribe outflow boundary conditions. To replicate the
physiologic effect of arterial networks distal to the CFD model, 3-element Windkessel
outlet boundary conditions were imposed using a coupled-multidomain method [79, 80].
This method provides an intuitive representation of the arterial tree beyond model outlets
and can be described by three parameters with physiologic meaning: characteristic
(regional) impedance (Rc), arterial capacitance (C), and peripheral resistance (Rp). The
total arterial capacitance (TAC) for control and corrected rabbits was determined from
inflow and BP measurements assuming an initial characteristic to total resistance (Rc:
Rp) ratio of 6% [81], and adjusted for the CoA group according to previous literature.
The TAC was then divided among the outlets according to their blood flow distributions
[80]. Once the capacitance terms for each branch were assigned, the terminal resistance
(Rt) was calculated from mean BP and flow measurements and distributed between the
Rc and Rp parameters by adjusting the Rc:Rt ratios to replicate measured BP using the
pulse pressure method [55]. These methods resulted in BP and flow waveforms similar in
shape and magnitude to the clinically measured BP and PCMRI flow values respectively
(figure 7) [82, 83].
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Figure 7. Representative CFD solid model with 3-element Windkessel outlet boundary
conditions displayed as circuit equivalents of the impedance at each model outlet.
Application of outlet boundary conditions results in pressure and flow values similar to
experimental measurements.

3.5.4 Simulations
CFD models were created for 7 subjects in each of the three groups described
previously: untreated CoA, corrected CoA, and control. Simulations were then performed
using a novel stabilized finite element method to solve equations for the conservation of
mass (continuity) and balance of fluid momentum (Navier-Stokes). Conservation of mass
can be expressed mathematically as:
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Where ρ is the fluid density and ux, uy, uz are the directional x, y, and z components of the
velocity vector.
The motion of incompressible fluids can be described by the governing
differential equations of Navier-Stokes and can be used to represent blood flow in the
fluid domain of the vessel lumen, from which the three-dimensional components of
velocity (ux, uy, uz) and pressure (p) can be determined. The equations can be expressed as
a set of coupled non-linear partial differential equations:

Where g is the acceleration due to gravity.
Vessels were modeled as rigid and blood was assumed to be Newtonian with a
density of 1.06 g/cm3 and a viscosity of 4cP consistent with previous reports of rabbits
[84] and upon consideration of shear rates observed in the current investigation.
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3.6 Simulation parameters
The following methods describe the simulation process for each subject. First, the
model was discretized into an isotropic finite element mesh with a maximum edge size of
0.5 mm, such that a ~500,000 element computational mesh was produced. Using mean
blood flow inlet boundary conditions and resistance outlet boundary conditions, a steady
simulation was then performed with the isotropic mesh. Mean BP and flow results for
each outlet were compared to values measured from catheter BP and PC-MRI data, and
adjustments were made to terms in the 3-element Windkessel models for each outlet to
ensure the mean simulation accurately matched physiological data (mean BP difference <
1 mmHg, mean flow difference < 5%). Following the first simulation, localized
refinement of the mesh elements was performed using an adaptation method which
regionally redistributes elements based on residual error of the CFD solutions [85, 86].
These methods resulted in an anisotropic mesh of roughly 3 million elements with
preferred minimum and maximum edge sizes dictated by the user.
Following adaptation, a mean simulation was performed on the new mesh to
initialize the flow domain in preparation for a pulsatile simulation. Pulsatile simulations
were performed for 4-6 cardiac cycles using the inflow boundary condition previously
described. The number of time steps per cardiac cycle for pulsatile simulations were
selected such that they satisfy a Courant-Friedrichs-Lewy (CFL) condition < 1.
Stabilized flow and BP measurements for each outlet were compared with
physiologic measurements. Pulsatile flow was averaged over the last cardiac cycle to
obtain a mean value, and mean pulsatile flow within 5% of targeted PC-MRI
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measurements was deemed acceptable, while systolic, diastolic, and pulsatile BP were
within 5mmHg of measured value based on previous research using CFD simulation
techniques [13, 87]. The procedure of adaptation, steady simulation, and pulsatile
simulation was subsequently performed until simulations met WSS mesh independence
criteria (discussed below).

3.7 Mesh independence
If indices of WSS are to be used as metrics to predict the risk or progression of
disease, it is important to ensure that calculation of these metrics is not influenced by
placement of mesh elements. An undersampled computational mesh may lead to
inaccurate indices of WSS that result in erroneous conclusions of the hemodynamic
influence on structural and functional alterations.
To this end, as mesh densities increased, TAWSS was quantified in 2mm
circumferential bands at four regions of interest: 1) ascending aorta, 2) proximal
descending thoracic aorta, 3) mid-descending thoracic aorta, and 4) descending thoracic
aorta just proximal to the diaphragm at identical locations in each mesh. For this study,
simulation results were deemed to be mesh independent when mean TAWSS at all of
these locations changed by less than 1% between successive meshes. Importantly,
previous CFD studies investigating hemodynamics in the abdominal aorta utilized mesh
independence criteria of 2% and 8% difference in TAWSS [87, 88], suggesting the
current methods apply sufficient criteria for spatial mesh independence. In general, final
meshes for the control group ranged from 2-2.5 million elements, while corrected and
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CoA models ranged from 2.5-3.5 million elements at completion. This discrepancy in
element number is due to the more continuous geometry and therefore decreased
complexity in blood flow patterns present in control rabbits and does not prevent
reasonable comparisons of hemodynamic parameters to be made across groups as all
simulations satisfied CFL conditions which account for element size and peak velocity.

3.8 Determination of indices of wall shear stress
Upon verifying that simulation results were mesh independent and replicated
aimed BP and flow distributions from clinical measurements, blood flow velocity, BP,
WSS, and OSI were visualized using Paraview software (Kitware Inc., Clifton Park, NY).
In its simplest form, WSS (τ) can be defined as:

where µ is dynamic viscosity, u the fluid velocity near the wall, and y the distance
from the wall, such that

is the velocity gradient near the wall. The accuracy of WSS is

therefore dependent on the proximity to the wall that velocity can be determined. In this
regard, CFD offers an advantage over calculation of WSS using other imaging
modalities. The resolution of the CFD model has the potential to be much higher than
PC-MRI based methods assuming the computational mesh is sufficiently resolved [89].

36
TAWSS and OSI were calculated [87] over the last cardiac cycle as previously
described [90]. Specifically, TAWSS was computed at each node on the surface of the
CFD mesh as:

Where

is the WSS vector at a node and T is the period of one cardiac cycle.

Similarly, OSI was computed at each surface node as:

OSI is a measure of the cyclic change in WSS over the cardiac cycle and thus
indicates the directionality of WSS. Lower OSI values indicate WSS is oriented
predominately in the primary direction of blood flow while a value of 0.5 is indicative of
bi-directional WSS with a time-average value of zero throughout the cardiac cycle.

3.9 Statistical analysis
Seven rabbits were used for each experimental group. Statistical analysis was
conducted using one-way multiple analysis of variance (ANOVA) followed by TukeyKramer multiple comparison test. Changes within and between groups were considered
statistically significant when P<0.05. Data are expressed as means ± standard error of the
mean (SEM).
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CHAPTER 4: QUANTIFY ALTERATIONS IN HEMODYNAMIC INDICES INCLUDING
BLOOD FLOW VELOCITY, WALL SHEAR STRESS, AND CYCLIC STRAIN AS
SURROGATES OF MORBIDITY IN A CLINICALLY REPRESENTATIVE MODEL OF
AORTIC COARCTATION AND REPAIR
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4.1 Review of rationale applicable to the current aim
Recent advancements in computational modeling may allow unique investigation
into the hemodynamic and biomechanical basis of morbidity associated with CoA. If
untreated and corrected CoA are associated with abnormal hemodynamics, future studies
may investigate modifications that restore favorable flow patterns. Although
computational modeling methods have recently been applied to CoA patients following
repair [14], results will be difficult to establish due to the limited number and
heterogeneity of patients at any given center, thus motivating the need for a
representative animal model.
The objective of this specific aim was to quantify the impact of pathophysiology
on hemodynamics and vascular biomechanics in the thoracic aorta using an animal model
representative of clinical CoA. Specifically, the goal of this aim was to reproduce
changes in indices observed in untreated CoA distinctly from those occurring with
correction of BP and morphology in a manner similar to surgical treatment of resection
and end-to-end anastomosis. The aim begins with a description of the animal model
developed for this purpose from which morphology, BP, and simulation indices of WSS,
OSI, strain, and velocity were observed using CFD techniques to quantify the severity of
the hemodynamic consequences caused uniquely by untreated CoA and correction to
determine if disparities are indicative of those previously associated with long-term
morbidity [72, 91, 92].
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4.2 METHODS UNIQUE TO THE CURRENT AIM

4.2.1 Calculation of hemodynamic indices
As mentioned in the previous chapter, simulations were conducted using a
parabolic velocity profile mapped to the inflow face and run for 4-7 cardiac cycles until
flow and BP results yielded periodic solutions, and indices of WSS including TAWSS
and OSI were found to be independent of the computational mesh. Previous imaging
studies found local low TAWSS and elevated OSI values that were statistically different
from circumferential averages [73, 93] motivating the need to report detailed local WSS
results in CFD studies. However, CFD modeling experiments present a unique challenge
of how to effectively present 3D data in a method that captures the immense amount of
information generated in a way that is both meaningful and succinctly understandable to
the reader. To this end, a number of quantification techniques are presented here to
provide a clear, concise, and thorough representation of the data from computational
simulations. This starts with a description of local quantification of hemodynamic results
and then techniques to display the full 3D vessel geometry in a 2D format that is easily
understandable.
Circumferential TAWSS or OSI values were extracted at locations corresponding
to near where histological and myograph analyses were conducted. Spatially equivalent
regions in the thoracic aorta were queried for all rabbits using the worst-case untreated
CoA rabbits as a guide. Thus, the proximal region represents the approximate midway
location between the LSA and coarctation, while the distal region represents the center of
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the impact zone created by the impinging velocity jet. The spatial location of these
regions was determined for each CoA model as the axial distance distal to the LSA outlet.
To account for variance in vessel shape and size, these distances were expressed in terms
of the number of diameter of the descending aortic outlet. The outlet diameter locations
for the proximal and distal regions were then averaged across the CoA group such that a
single normalized outlet diameter multiple was obtained for the proximal and distal
locations to be applied to all models. The distal end of the LSA served as a marker
position for the origin of axial plots based on previous work detailing the influence of the
aortic valve at locations proximal to the LSA (discussed in limitations).
Circumferential results at each location were divided into 16 sectors of equal size
and values within each sector were averaged in order to quantitatively determine the
degree of localized hemodynamic alterations due to CoA and correction. Values for each
sector were extracted using a series of Matlab scripts. First, a .vtk file corresponding to
the TAWSS or OSI of the model was loaded, from which three mesh variables were
stored: 1) vertices, containing x,y,z coordinates of the mesh nodes, 2) connectivity,
detailing node and element connections, and 3) scalars, containing TAWSS or OSI values
for each node.
A plane orthogonal to the path was then determined along the centerline at the
locations mentioned above. Circumferential points were then mapped to a virtual set of
cylindrical points, and the vessel centerline mapped to the z-axis via a series of rotations.
Circumferential position was calculated by the arctangent of the (x,y) components of the
points. The (x,y,z) coordinates and WSS indices for points from 0 to 360 degrees were
found by interpolating at the four nearest nodes.

41
4.2.3 Visualization
In order to visualize indices of WSS, the vessel surface was unwrapped and
mapped to a cylindrical (θ, l) coordinate system, where θ represents the angular position
(0-360 degrees) of the node. The zero degree landmark was selected to lie along the inner
curvature of the vessel. The dimension l represents the axial length along the vessel in
which the node was located, and is measured relative to the centerline path created during
model construction. However since this pathway was user-created, it may not accurately
represent the center of the vessel. To adjust the centerline, a circle fitting algorithm was
used to fit circles to the vessel at a specified number of evenly spaced locations along the
original path. Fitted circles were preferred over a centroid method as centroids would be
skewed away from bifurcating vessels. From the adjusted centerline, the (x,y,z) points
were stored and used to unwrap the vessel.
The vessel was divided along the inner curvature of the vessel and displayed as a
flat surface. From the unwrapped vessel, TAWSS values were queried at locations along
the thoracic aorta at specified axial increments using the worst-case CoA group as a guide
previously discussed.

4.2.4 Cyclic strain
Cyclic vascular strain and associated mechanical properties were delineated from
PC-MRI data acquired at the ascending aortic inlet. Luminal diameter was segmented
over the 20 frames of the cardiac cycle using 2D manual techniques. Maximum and mean
Green-LaGrange strain (Eθθ) was calculated as:
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And

where D=diameter and Ddiastolic is its reference value during diastole. Pressure-strain
elastic modulus (Ep) was subsequently determined as:

Where ∆BP = systolic BP – diastolic BP, and ∆D = maximum diameter – minimum
diameter.
Aortic distensibility, an index of aortic elasticity, was calculated based on
previous research [94] as:

4.3 RESULTS
4.3.1 Morphology
Maximum intensity projections (Figure 8) of the acquired MRA data confirmed
that rabbits undergoing coarctation with silk suture developed a pronounced stenosis
following surgery, similar to untreated CoA in humans. Rabbits undergoing CoA with
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degradable Vicryl suture initially developed stenosis, however degradation of the suture
after 56-70 days returned aortic diameter close to that of controls with modest residual
narrowing present in the suture region. These morphological characteristics are similar to
human surgical treatment of resection with end-to-end anastomosis, the most common
method of surgical intervention in CoA. Control rabbits represented healthy subjects of
similar age and weight. There were no differences in body weight between rabbits in each
experimental group at the conclusion of the experimental protocol (control: 3.1 kg, CoA:
3.0 kg, corrected: 3.2 kg)

Figure 8. Maximum intensity projections (MIPs) from rabbit imaging data, n=7 rabbits
presented for each group.
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4.3.2 BP data
Rabbits undergoing coarctation with silk suture demonstrated a significantly
increased (P<0.05) mean BP gradient of 20 ± 2.0 mmHg across the proximal and distal
aortic catheter locations compared to control and corrected groups (Figure 9). In contrast,
corrected rabbits showed significant alleviation of the BP gradient (2.7 ± 1.3 mmHg;
P<0.05).

Figure 9. Mean blood pressure gradient from rabbits in each experimental group, taken
as the difference between fluid-filled catheter measurements in the carotid and femoral
arteries.  = CoA significantly different (P<0.05) from control; § = CoA significantly
different (P<0.05) from corrected.

Representative waveforms show increased proximal systolic and mean BP in CoA
rabbits (Figure 10). Corrected rabbits show BP waveforms similar to control as well as
systolic and mean BP significantly less than the CoA group.
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Figure 10. Representative ensemble-averaged waveforms from rabbits in each
experimental group. Solid lines indicate proximal (carotid) BP measurements and dashed
lines indicate distal (femoral) BP.

Distal artery BP recordings revealed no significant differences in systolic or mean
BP across all groups (Table 3), however pulse BP was significantly reduced in the CoA
group compared to controls (5.5 ± 1.5 mmHg vs. 25.4 ± 1.4 mmHg respectively; P<0.05).

Control

CoA

Corrected

Systolic BP

71 ± 3

99 ± 7*§

69 ± 3

Mean BP

64 ± 4

87 ± 8*§

61 ± 4

Diastolic BP

58 ± 4

74 ± 10

54 ± 4

Pulse Pressure

13 ± 1

25 ± 4*§

16 ± 1

Systolic BP

78 ± 5

70 ± 9

73 ± 4

Mean BP

61 ± 4

67 ± 9

58 ± 4

Diastolic BP

52 ± 4

64 ± 8

50 ± 4

Pulse Pressure

25 ± 1

6 ± 2*§

22 ± 1

Proximal

Distal

Table 3. Blood pressure measurements (mmHg) obtained at carotid (Proximal) and
femoral (distal) locations. Values are means ± SEM, n=7/group.  = CoA
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significantly different (P<0.05) from control;  = corrected significantly different
(P<0.05) from control; § = CoA significantly different (P<0.05) from corrected.

4.3.3 Velocity, TAWSS, and OSI
Representative solid models for all rabbits are shown in Figure 11. Rabbits
undergoing coarctation developed tortuosity distal to the stenosis that was more severe
for CoA than corrected rabbits.

Figure 11. CFD solid models created from volumetric imaging data. Control subjects
(top row), untreated CoA (middle row), and corrected CoA (bottom row). Models began
at the aortic sinus and terminated at the location of the diaphragm.

Systolic velocity patterns for all rabbits are similarly shown in Figure 12.
Velocity profiles at peak systole in control rabbits were generally parabolic with values
~60 cm/s present throughout the aorta and branches. CoA rabbits show lower velocity in
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the aortic arch, a dramatic velocity jet due to the coarctation, and a region of post-stenotic
dilation and tortuosity distal to the coarctation. Corrected rabbits demonstrate a region of
increased velocity at the coarctation site where residual narrowing was present, and
reduced velocity magnitude in the distal region where a moderate dilation is present.

Figure 12. Peak systolic velocity simulation results in control subjects (top row),
untreated CoA (middle row), and corrected CoA (bottom row).

Global TAWSS results (Figure 13) followed trends consistent with associated
velocity distributions. Control rabbits had fairly consistent distributions of TAWSS,
particularly in the dAo, ranging from 15-20 dynes/cm2. CoA rabbits showed marked
differences including regions of low TAWSS proximal to the coarctation and extremely
high TAWSS at the location of velocity jet impingement distal to coarctation. The
corrected group revealed a small region of increased TAWSS at the site of residual
narrowing and reduced TAWSS distal to the coarctation.
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Figure 13. Time-averaged wall shear stress simulation results in the control subjects (top
row), untreated CoA (middle row), and corrected CoA (bottom row).

OSI, an index of flow separation, demonstrated values generally ranging from
0.20-0.25 in controls, while CoA rabbits had elevated OSI immediately distal to the
coarctation and in the tortuous region (0.40-0.50). These trends were similarly present in
corrected rabbits, but to a lesser degree (0.35-0.45; Figure 14).
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Figure 14. Oscillatory shear index in the control subjects (top row), untreated CoA
(middle row), and corrected CoA (bottom row).

Control

CoA

Corrected

Proximal

6.960 ± 0.168

7.358 ± 0.232

6.847 ± 0.242

CoA stenosis

6.605 ± 0.172

1.894 ± 0.080*§

6.175 ± 0.247

Distal

5.753 ± 0.124

9.529 ± 0.225*§

8.353 ± 0.355†§

Table 4.Vessel diameters for CFD models. Values are means ± SEM, n=7/group.  =
CoA significantly different (P<0.05) from control;  = corrected significantly different
(P<0.05) from control; § = CoA significantly different (P<0.05) from corrected.

4.3.4 Circumferential TAWSS
TAWSS results unwrapped about the inner curvature of the dAo are presented in
Figure 15. Proximal to the coarctation, CoA rabbits had significantly reduced TAWSS
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compared to controls (P<0.05) along the outer wall, but no differences were observed in
the corrected group.
In the distal region, CoA TAWSS was significantly elevated at the site where the
velocity jet impinged in the outer left wall (100-130 dynes/cm2 greater than control,
P<0.05). In contrast, corrected rabbits showed significantly reduced TAWSS in the inner
right luminal wall compared to controls (3.3-5.4 dynes/cm2 in corrected vs. 13.8-17.5
dynes/cm2, P<0.05) at this location.
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Figure 15. Unwrapped TAWSS data maps for each rabbit (left columns). Schematic of spatial
sectors and locations for TAWSS data (top right). Locations where circumferential TAWSS data
were quantified at proximal and distal regions are indicated by hashed lines on TAWSS maps
(middle left). Distal unwrapped TAWSS results are shown (bottom right) with a range to account
for all data, as well as a magnified scale to clarify differences between control and corrected
groups. Values are means ± SEM, n=7/group.  = CoA significantly different (P<0.05) from
control;  = corrected significantly different (P<0.05) from control; § = CoA significantly
different (P<0.05) from corrected.
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4.3.5 Cyclic Strain
CoA and corrected rabbits demonstrated significantly (P<0.05) reduced mean and
maximum strain at the ascending aorta as well as distensibility compared to controls, with
CoA rabbits showing pronounced reductions as compared to the corrected group (Table
5). Pressure-strain elastic modulus was significantly increased in CoA rabbits
(47.2±4.66*103 N/m2, P<0.05) compared to both controls (8.46±1.05*103 N/m2) and
corrected (15.6±1.39*103 N/m2) rabbits, indicating increased stiffness in the CoA group.
Ascending aortic diameter in CoA rabbits was significantly greater (P<0.05) than
controls: 8.976 ± 0.393 mm vs. 7.531 ± 0.225 mm. Corrected rabbits showed a slight
increase in mean diameter (8.137 ± 0.195 mm), but this did not reach significance.

Control

CoA

Corrected
§

0.068 ± 0.004†
0.156 ± 0.003†

Mean Eθθ

0.138 ± 0.013

0.044 ± 0.004*

Max Eθθ

0.274 ± 0.025

0.082 ± 0.005*§

Modulus, N/m2

8.46E+03 ± 1.05E+03 47.2E+03 ± 4.66E+03*§

15.6E+03 ± 1.39E+03

Mean Diameter, mm

7.531 ± 0.225

8.976 ± 0.393*

8.137 ± 0.195

Aortic Distensibility

0.038 ± 0.005

0.008 ± 0.002*§

0.019 ± 0.002†

Table 5. Strain parameters delineated from PC-MRI imaging data. Values are means ± SEM,
n=7/group.  = CoA significantly different (P<0.05) from control;  = corrected significantly
different (P<0.05) from control; § = CoA significantly different (P<0.05) from corrected.
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4.4 SUMMARY
Research has indicated the conduit and cushioning functions of the thoracic aorta
are influenced by CoA in a manner that may cause persistent changes to vascular
biomechanics and hemodynamics despite removal of the stenosis. Unfortunately the
scarce number of affected human patients at any given center and their heterogeneity in
terms of treatment or accompanying co-conditions severely limit analysis of
hemodynamic alterations caused directly by the CoA. Therefore the objective of this
specific aim was to quantify the impact of CoA pathophysiology on hemodynamics and
vascular biomechanics of the thoracic aorta in an animal model representative of clinical
CoA and correction in human patients. Putative criteria for surgical intervention (a mean
BP gradient ≥20 mmHg) in CoA was established in the untreated CoA group,
demonstrated by the presence of a significant mean BP gradient compared to control and
corrected groups, as well was an increased systolic BP. Importantly, the corrected group
demonstrated a complete alleviation of mean BP gradient, with systolic BP and mean BP
similar to controls, thus mimicking critical clinical criteria of successful end-to-end
anastomosis repair of coarctation. As compared to previous research studying
pathophysiology of induced CoA [95-97] often using animal models with excessively
large BP gradients that may result in vascular phenomena not normally associated with
CoA, the current methods benefit from a more realistic representation of BP gradient. In
the current study, morphological characteristics were in agreement with clinical findings,
as the CoA group demonstrated development of a stenosis, post-stenotic dilation, and
tortuosity similar to that of untreated CoA patients, while corrected rabbits showed
modest residual narrowing at the location of CoA and a slight dilation distal to the
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stenosis. The methods described therefore provide evidence that significant alterations to
indices of hemodynamics and vascular biomechanics occur due to CoA and persist
despite BP restoration. These methods also provide an animal model of coarctation that
facilitates longitudinal studies to determine long-term consequences of the disease that is
completely independent of confounding genetic or developmental factors.
The current aim used this model coupled with CFD to analyze the degree of
localized alterations to hemodynamic indices of WSS, OSI, and blood velocity due to
untreated and corrected CoA. Peak velocity was parabolic with a magnitude ~60 cm2/s
throughout the thoracic aorta of control rabbits, while untreated rabbits demonstrated
reduced velocity above the stenosis and a stenotic velocity jet in the descending aorta.
Corrected rabbits showed modest flow acceleration in the region of residual narrowing,
and slightly reduced velocity in the distal dAo at the location of modest dilation. Results
from TAWSS data complimented these velocity observations. In CoA rabbits, reduced
TAWSS was present proximal to the stenosis, while the pronounced velocity jet causes
increased TAWSS distally and appears to play a role in the tortuosity observed. Corrected
rabbits show reduced TAWSS in the distal region, and these are likely caused by
morphological changes associated with the impinging velocity jet during CoA.
The current results of velocity distribution in control rabbits are in agreement with
previous research which characterized flow in the thoracic aorta of healthy adults using
3D MRI [57, 72, 73]. Previous work using CFD methods similar to those used in the
current aim demonstrated flow patterns reflective of these trends, which involved mainly
axial flow during early systole, and helical flow patterns in the descending aorta [14, 57].
Subsequent analysis of age and gender matched patients following CoA correction with
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resection and end-to-end anastomosis showed alterations to WSS in the form of low
TAWSS distal to the stenosis due to re-circulating flow. The current CFD results
demonstrated parabolic flow during peak systole in controls and reduced velocity and
WSS distal to the stenosis in corrected subjects, thus agreeing with flow patterns in both
control and corrected human subjects from previous 3D MRI and CFD studies. This
supports the comparison of hemodynamic indices using the current CFD methods. The
results indicate that changes in vascular morphology due specifically to CoA induce
alterations in indices of velocity and WSS in untreated and corrected CoA which are
independent of developmental factors.
Regions of low TAWSS appear to be predisposed to atherosclerosis in the
thoracic aorta [72], however little is known about alterations in TAWSS due to CoA. The
current methods allow understanding and quantification of critical hemodynamic indices
at multiple scales in a more accurate manner than conventional ultrasound based
methods. The results indicate CoA causes hemodynamic alterations above and below the
stenosis, and that alterations distal to the stenosis may lead to persistent hemodynamic
changes that persist despite BP alleviation. From a clinical perspective, these findings
may be used to augment treatment techniques in coarctation either by considering patient
outcomes based on the severity of hemodynamic alterations as a result of correction, or
by development of treatment techniques which result in minimal disturbance to
hemodynamic indices.
Arterial stiffening was observed in untreated and corrected CoA through vascular
biomechanics indices of reduced distensibility and strain. Alterations to resting
biomechanical properties are typically reflective of changes in collagen, elastin, and

56
medial thickness [98], and aortic stiffening causes increased cardiac afterload and
decreased coronary perfusion [10]. Thus, the ability of the current methods to determine
localized alterations in both CoA and corrected subjects is useful in understanding
possible causes of late morbidity in patients following surgical correction of CoA.
Reduced strain in the untreated group is likely due to the downstream coarctation,
however results from the corrected group indicates that resting tension remains elevated
despite BP alleviation. This finding is in agreement with previous studies suggesting
altered vascular properties persist despite treatment [46]. These abnormalities are likely
to contribute to the development of late systolic hypertension and atherosclerosis.
In summary, by quantifying hemodynamic and vascular biomechanics indices in a
representative animal model of CoA and correction, these results indicate the
ramifications of coarctation go far beyond the removal of the BP gradient, as altered
hemodynamic and vascular biomechanics indices persist under these treatment
guidelines. The incorporation of patient-specific outlet boundary conditions allows
clinical measurements of pressure and flow to be replicated in CFD results and illustrate
the benefits of including flow disturbances caused by CoA. These CFD methods may be
extended to identify specific cellular mechanisms affected by altered hemodynamics in
CoA.

4.5 Limitations
Results from the current aim should be interpreted within the constraints of
several potential limitations. Notably, CFD models in the current methods used rigid
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walls that do not account for deformability, which may provide more complete
information of hemodynamic alterations but were not implemented into the current model
due to the immense computational cost required for larger models. Spatial changes in
tissue mechanical properties were not considered which may be of particular concern as it
has been shown that 60% of total arterial capacitance is located in the proximal thoracic
aorta and decreases distally leading to tissue properties that account for increased rigidity
and pulse wave amplification relative to the upstream locations [4]. Recent advances in
CFD modeling are now beginning to account for spatially-varying tissue properties [99],
and future implementation of these methods may allow a more accurate simulation of
pulse BP changes in coarctation, as the current CFD results appear to underestimate this
value. Results presented from CFD simulations should also consider fluid dynamics of
the rabbit vasculature. Importantly, mean Reynold’s number in the ascending aorta of the
current rabbits ranged from ~260-300, while previous studies investigating CoA in
humans demonstrate mean Reynold’s numbers of ~1100-1500 [14]. Although these data
confirm the assumption of laminar flow in both cases, differences present in the flow
regime of rabbits suggest viscous-dominated flow is present, while human aortic flow is
inertially-dominated. An important implication for evaluation of hemodynamics is that
turbulence and secondary flows are not likely to occur in the rabbit aorta, whereas they
may be present in the human thoracic aorta. Additionally, a parabolic velocity profile
was used as to map the PCMRI flow data to the inflow face. Recent work by this lab has
demonstrated that inclusion of the aortic valve geometry at the inlet boundary condition
can influence hemodynamic indices in the ascending aorta as far as the LSA. In lieu of
implementing subject-specific valve anatomy into the current CFD models, this limitation
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was addressed by truncating quantitative analysis of hemodynamics to regions distal of
the LSA, as the influence of valve inclusion is limited to this region in previous analysis.
It cannot be confirmed that mesh independence was reached at all locations of the
CFD simulation in each subject. Although there were some portions where mesh
independence was achieved, the areas were selected with no consideration for regions of
complex flow or vessel tortuosity, both of which could influence regional variations in
TAWSS.
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CHAPTER 5: COMPARE STRUCTURAL CHANGES IN THE ARTERIAL WALL
ACCOMPANYING COARCTATION-INDUCED ALTERATIONS IN HEMODYNAMICS
AND VASCULAR BIOMECHANICS USING HISTOLOGICAL TECHNIQUES
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5.1 Review of rationale applicable to the current aim
Despite successfully alleviating the BP gradient by surgical treatment, CoA is
associated with persistent morbidity. The previous chapter revealed important local
alterations in hemodynamic and vascular biomechanics indices that have been previously
linked to cardiovascular morbidity. Additionally, long-term clinical evaluations of CoA
patients have detailed structural changes present in the proximal arteries of post-repair
patients in the form of increased IMT [61, 65], a clinical marker for atherogenic risk.
Further research regarding the timeline of surgical intervention found that early repair (<6
months) seems to benefit the aortic wall distal to CoA but does not similarly benefit the
aortic wall proximal to CoA. Since surgery as early as the neonatal stage (1-2 months)
does not fully alleviate structural abnormalities [61, 62], there is currently some debate as
to whether the source of these structural changes is caused by hemodynamic forces from
the damaging effects of raised arterial BP due to CoA or rather developmental factors
present in the congenital CoA pathology.
Acute hypertensive models have established that localized increases in BP are
associated with increased vascular thickness [16, 74]. These changes are thought to occur
as a result of homeostatic mechanisms in response to the sustained BP increase whereby
wall thickness increases and luminal radius remains constant, thus reducing wall stress.
Pressure induced medial thickening may occur through various mechanisms including
hypertrophy, hyperplasia, and extracellular matrix remodeling [34, 100, 101]. Similarly,
sustained reductions in flow and subsequently WSS are associated with increased vessel
thickness through neointimal hyperplasia [102-104] due to WSS homeostasis. Untreated
and corrected CoA may cause notable alterations to hemodynamic indices of WSS as
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previously illustrated, and these alterations are typically associated with vascular
remodeling. While clinical studies are beginning to utilize ultrasound-based methods to
investigate localized hemodynamics and IMT in human CoA patients, understanding of
these structural changes is limited, particularly in corrected CoA. The current model
improves on research in this regard by providing a coupled imaging and experimental
method by which highly accurate localized WSS quantification can be compared to
precise measurements through histological techniques in untreated and corrected CoA. In
addition to quantifying overall changes to medial thickness, evaluation of SMC
phenotypic modulation markers smooth muscle (SM) α-actin, non-muscle myosin (NM
myosin), smooth muscle myosin heavy chain (SM MHC), and caldesmon is feasible
using the current methods and may further clarify how altered hemodynamics and
vascular biomechanics may influence structural changes.
Maintenance of arterial structure and function is critically dependent on controlled
differentiation of highly specialized vascular smooth muscle cells [100]. A change in
differentiation of smooth muscle cells has been demonstrated to occur in conditions of
vascular injury [100, 105], and these changes may thus be present in CoA [105, 106].
NM myosin is a motor protein that plays a role in cellular force and translocation through
its actin-binding and contractile properties. Although NM myosin is distinguished as a
non-muscle protein, it is present in muscle cells and has several functions. Through
development, differentiation is thought to occur such that NM myosin expression
decreases from ~50% in embryonic stages to less than 10% in mature animals [107].
However recent research has increasingly indicated that NM myosin can uniquely
provide a convergence point between external forces and cellular responses that regulate
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its activation [108], thus providing a possible link between altered hemodynamics and
biomechanics and structural surrogates of morbidity observed in untreated and corrected
CoA. External forces may result in phosphorylation or conformational changes in NM
myosin which subsequently alter cytoskeleton mobility and filament interaction,
ultimately leading to changes in smooth muscle migration and adhesion [109]. While
several reports have documented a mechanosensitive role for NM myosin in cell culture
experiments [110, 111], no studies to date have observed the expression of vascular NM
myosin in pathophysiological conditions where biomechanics can be accurately
quantified. These alterations may serve to affect phenotypic expression of smooth muscle
differentiation marker proteins specifically by altering NM myosin, which may play a
role in the remodeling and functional response.
The current aim seeks to advance research in this area by using a rabbit model
capable of mimicking untreated and corrected CoA and free of genetic or other
confounding factors. The objective of this aim was to compare structural alterations
present in untreated and corrected CoA to control subjects using histological techniques
and immunhistochemical analysis. From the experimental model, vascular medial
thickness and expression of key smooth muscle differentiation proteins can be obtained in
spatial locations of interest proximal and distal to the CoA in each of the groups. The
presence of structural abnormalities and altered phenotypic expression of smooth muscle
differentiation proteins in groups of untreated and corrected CoA would suggest that
alleviation of BP does not address structural changes caused specifically by CoA
pathology, independent of developmental factors. When compared with local alterations
from CFD, histological and immunohistochemical changes could further elucidate the
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cause of substantial morbidities potentially leading to reduced life expectancy and
persistent morbidity in post-repair human CoA patients.

5.2 METHODS

5.2.1 Harvest of arteries
The animal model for this specific aim has been described in detail in Specific
Aim 1. Following BP catheter measurements, rabbits remained on anesthesia and were
prepared for excision of arteries at 32 weeks. The chest was opened via midline
sternotomy and the left ventricular apex was incised for perfusion with 400-500 mL of
lactated ringer’s solution while the rabbit was exsanguinated via femoral vein incision.
Rabbits were then humanely euthanized by intravenous overdose of pentobarbital sodium
(100 mg/kg), and arteries from the descending thoracic aorta proximal and distal to CoA,
LCCA, and femoral were excised and immediately fixed with 10% neutral buffered
formalin for histology. Additional sections from the thoracic aorta proximal and distal to
CoA were excised for immunohistochemistry as described below. In order to orient
arteries for consistent histological measurements, samples were denoted to mark the
region closest to the CoA suture and the outer wall using either suture tied to the fascia or
tissue landmarks.
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5.2.2 Fixation
Fixation with 10% neutral buffered formalin prevents autolysis and putrefaction
by creating covalent chemical bonds between proteins and to maintain cells in a natural
state for histological observation. This fixative is buffered to a neutral pH to avoid
possible damage to blood cells. In addition, formalin permits restoration of natural color
to tissues and is thus useful for optimizing light microscopy observation of sections.
Previous research has indicated a general minimum guideline of 8-36 hours for fixation
time of paraffin-embedded tissues [112-114], and thus a fixation time of at least 48 hours
at room temperature was used for all arteries.

5.2.3 Infiltration
After fixation, arteries from the regions mentioned above underwent a controlled
infiltration protocol to remove water from the tissue and replace with a solid medium in
preparation for sectioning. Samples were dehydrated in graded baths of progressively
increasing concentrations of ethanol (70% - 100% EtOH), followed by a clearing agent
(xylene) miscible in alcohol. Samples were then infiltrated with molten paraffin wax
prior to sectioning for light microscopy at 5 µm. Previous research with vascular sections
indicates that paraffin provides a sufficiently hard surface to allow sectioning at this
thickness [16].
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5.2.4 Orientation, embedding, and sectioning
Arteries were embedded in paraffin wax following infiltration and arteries from
the descending aorta were oriented such that sections would be obtained from the region
closest to CoA and by notching the paraffin blocks at tissue landmark locations denoting
the outer wall. Resulting paraffin blocks were sectioned on a microtome (Leica RTS;
Wetzlar, Germany) and collected. Sections were floated on a warm water bath to avoid
wrinkling, mounted on clear glass slides, labeled, and allowed to dry.

5.2.5 Staining protocol
Verhoeff Van Gieson staining was used to identify medial borders including the
internal and external elastic lamina (IEL and EEL, respectively) and elastic fibers. During
this protocol, the tissue is stained with a regressive hematoxylin, composed of ferric
chloride and iodine. Differentiation is accomplished by using excess ferric chloride
(mordant) to break the tissue-mordant complex. Since elastic tissue has the strongest
affinity of the iron-hematoxylin solution, it retains the dye longest and thus remains
darkly colored. Briefly, sections were first deparaffinized and hydrated to distilled water
by exposure to successively decreasing concentrations of ethanol. Slides were then
immersed in Verhoeff’s hematoxylin for at least 30 minutes to stain the tissue completely
black. Following a brief wash in tap water, sections were differentiated in a 2% ferric
chloride solution. This step was performed by periodic microscopic observation for black
fibers against a gray background. Extreme care was taken during the regressive staining
step to repeatedly observe coloration of samples without damaging adherent tissue to
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ensure proper differentiation of the vascular tissue occurred that would allow qualitative
and quantitative analysis (Figure 16). Sections were quickly rinsed with water and
counterstained with Van Gieson’s solution to color collagenous elements red. Upon
completion, the sections were dehydrated rapidly, cleared in xylene, and coverslipped
using a permount medium [115].

Figure 16. Example of correctly differentiated Van Gieson stained image (left) and
overdifferentiation (right) with luminal border on the left and the adventitial side on the
right. Elastic laminae and medial borders are obscured throughout (right) due to
excessive differentiation with ferric chloride.

5.2.6 Image capture, calibration, and quantification
Digital images of stained sections were collected for qualitative and quantitative
observation using a Zeiss light microscope at 6.3x and 16x objective magnifications and
stored using IM50 software before color and contrast balancing was performed.
Quantification of medial thickness (distance between IEL and EEL) and remodeling area
(medial region of elastin fragmentation and discoloration measured radially from the
IEL) was subsequently analyzed using ImageJ and appropriate calibration for
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magnification strength. Measurements of medial thickness were obtained by use of lines
normal to the lumen to accurately measure radial thickness and avoid possible errors due
to the natural curvature of the arterial region of interest (Figure 17). The medial area of
arteries was also calculated by tracing the EEL and IEL and subtracting the respective
areas to account for possible differences in lumen radius and vessel thickness occurring
due to artery fixation and varying pressures. For histological analysis, seven rabbits were
used for each experimental group. 5 µm sections from each spatial location of interest
were taken for each rabbit from which nine measurements were averaged to obtain an
estimate of medial and remodeling thickness for each subject. Quantification was
conducted in triplicate by three investigators blinded to the experimental group.

Figure 17. Example of Van Gieson stained image and quantification of medial thickness.
Green lines indicate where measurements of medial thickness from inner elastic laminae
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to external elastic laminae were made using ImageJ. Measurement lines are normal to
the lumen to ensure consistent quantification of thickness.

5.2.7 Immunohistochemistry
To understand the process of structural adaptation in CoA and correction, there is
a need to quantify changes in phenotypic modulation of the vascular wall. As such the
expression of selected standard SMC differentiation marker proteins [116] were
evaluated at proximal and distal dAo locations: SM α-actin, NM myosin, SM MHC, and
caldesmon. SM α-actin and SM MHC are isoforms of contractile proteins and are thus
excellent markers of the differentiation state of SMC [100]. Caldesmon is an actin and
calmodulin-binding protein that has been detected in SMCs and various non-muscle cells
[117]. When considered together, expression of these proteins may provide a more
sensitive indicator of SMC differentiation than the common use of SM α-actin or SM
MHC alone. Tissue specimens from the regions described above were cleaned of blood
and loose connective tissue and frozen or isopentane cooled in liquid nitrogen and stored
at -80C. 8 um sections were cut on a Leica CM 1900 cryostat, mounted on glass slides,
and stored at -20C until used.
Tissues were treated as previously reported [118]. Frozen sections were fixed with
2% paraformaldehyde for 10 min, permeabilized in 0.5% Triton X-100 for 10 min, and
blocked with 5 mg/mL bovine serum albumin (BSA) for 1 hour. Sections were reacted
with primary antibody for 2 hours and the appropriate secondary antibody for 2 hours,
incubated with DAPI (0.5 uM) for staining nuclei, and coverslipped. Multiple washes
were used after primary and secondary incubation to avoid non-specific binding. All
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immunoreacting solutions were made in PBS-Tween with 0.1% bovine serum albumin
(BSA) as carrier. Antibodies were obtained from the following sources: SM α-actin (A
2547), SM MHC (F0791), Talin (8D4), Fibronectin (IST-3) and Caldesmon (T3287)
from Sigma Chemical Co (St. Louis, MO); NM myosin (BT-561) from Biomedical
Technologies Inc (Stoughton, MA) ; Cy2 and Cy3 secondary antibodies from Jackson
immuno Research (West Grove, PA), and DAPI (157574) from Molecular
Probes/Invitrogen (Eugene, OR).
Sections were observed with an Olympus IX70 microscope with epifluorescense
illumination. Digital images were taken with 16-bit Princeton Instruments camera
controlled through PCI board via IPLab for Windows. In order to view the relatively
large media of aortic sections, all images were taken at 10X air lens. Quantitative analysis
was performed using ImageJ software. Grayscale images for SM α-actin, NM myosin,
SM MHC, caldesmon, fibronectin, and talin were collected using similar light intensity
and exposure times for all samples. For quantitative comparison of SMC protein
expression, mean optical density was determined from 3 randomly chosen regions of
interest of equal size from each animal (9-15 per group) which spanned the entire medial
wall in each region and the mean optical density was determined. For each protein, data
was expressed as average values of staining intensity (unitless) ± SEM. Three to five
animals were quantified for each experimental group.
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5.2.8 Statistical procedures used for data analysis
Statistical analysis of histological and immunhistochemistry data was conducted
based on criteria previously outlined in the methods common to all specific aims.

5.3 RESULTS
Histology
Figure 18 shows representative Verhoeff Van Gieson stained images at each
region as well as total medial thickness, where hashed portions of the plot indicate the
amount of media containing disorganized or fragmented lamellae not present in the
control group. The current histological methods using Van Gieson’s staining uniquely
allows detailed observation of elastic fibers and was thus preferred to more traditional
staining techniques using hematoxylin and eosin. In both LCCA and proximal dAo
regions, total medial thickness was significantly increased in CoA and corrected groups
compared to controls (P<0.05) with pronounced elastin fragmentation. These differences
in medial thickness were not present downstream of the CoA in the distal dAo or femoral
arteries. However disorganized lamellae were also present in the corrected group and to a
lesser degree in CoA rabbits in the distal dAo. Elastic laminae are not normally present in
the medial layer of femoral arteries and neointimal hyperplasia was not observed in any
sections resulting in a remodeling thickness of zero in these distal vessels.

71

Figure 18. Verhoeff Van Gieson stained arterial sections representative of those obtained
proximal and distal to the coarctation region in CoA and corrected groups as compared
to spatially equivalent locations from control rabbits. Hashed portions of the plots
indicate the amount of the medial layer containing fragmented lamellae devoid of darklystained elastin. Upward error bars correspond to the SEM for the entire medial thickness
while downward error bars represent the SEM for hashed portions of the plots.  =
significantly different (P<0.05) from control.

Arteries were not fixed at a defined pressure and thus differences in lumen area
and medial thickness may be present as evidenced by previous research [119]. In order to
address this limitation, Figure 19 shows quantified medial area in proximal and distal
aortic segments in measurements. Proximal results show CoA and corrected medial area
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were significantly increased compared to control (P<0.05) while no differences where
present distally, similar to thickness results observed.

Figure 19. Quantification of medial area (displayed as um2) from histological segments
to account for possible differences in fixation pressure. Area measurements were
obtained by tracing EEL and IEL borders and subtracting respective areas. Error bars
correspond to the SEM for the medial area.  = significantly different (P<0.05) from
control

Immunohistochemistry
NM myosin staining intensity was significantly increased in proximal dAo
arteries of both CoA and corrected rabbits compared to control (87.0 ± 6.4 and 83.2 ± 3.6
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respectively vs. 37.6 ± 2.6, P<0.05) (Figure 20). These differences were not present in
the distal dAo region. No significant differences were observed in fluorophore intensity
radially across the media. The use of histograms to further detect any spatial trends in the
distribution of NM myosin under experimental conditions also did not yield any
significant differences. SM MHC staining intensity of proximal arteries was significantly
reduced in CoA and corrected groups compared to controls (51.6 ± 4.4 and 57.7 ± 5.8
respectively vs. 117.8 ± 11.2, P<0.05), while no significant differences in SM MHC
intensity were present distally. Caldesmon intensity was significantly reduced in
proximal arteries of CoA rabbits, while no differences were present distally (Caldesmon
data not shown). There were also no statistical differences in Talin, Fibronectin, or SM αactin staining intensity across groups (Talin and Fibronectin not shown).
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Figure 20. Representative micrographs of immunohistochemical staining of proximal
(top row) and distal (bottom) aorta with NM myosin, SM MHC, and SM α-Actin.
Quantified staining intensity (mean ± sem) for each location and group (right).  =
significantly different (P<0.05) from control
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5.4 SUMMARY

Histology
Structural analysis of arteries in various pathophysiological conditions has been
performed for some time [64, 91, 98, 103, 120, 121]. Studies typically observe medial
thickness, intimal thickness, or volume using either a singular response or serial studies
to observe the time course of associated changes [36, 74]. The current investigation uses
a reproducible method by which structural changes in the arterial wall can be observed in
the setting of untreated and corrected CoA at locations near the coarctation and in the
distal vasculature to observe changes in the structural properties of conduit arteries
relative to local hemodynamic alterations quantified from CFD. Results indicate that
structural abnormalities in the form of increased medial thickness, medial area, and
elastin fragmentation exist in proximal arteries of untreated CoA and persist in the
corrected group despite restoration of a normal BP and BP gradient for 12 weeks (the
equivalent of 4 human years). Previous research demonstrates minor changes in luminal
radius and wall thickness may be present at different intraluminal pressures which cannot
be accounted for using thickness measurements. Medial area was quantified to account
for this discrepancy, and statistical trends were similar to thickness results.
The fact that differences in medial thickness and medial area were confined to the
proximal arteries supports the theory of a hypertensive vascular remodeling response, as
BP was increased in these regions permanently in the untreated CoA group, and
transiently in the corrected group. Previous research with hypertensive animal models has
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identified this response as a compensatory mechanism by which the vessel seeks to
restore wall stress homeostasis [36, 106, 122]. This increased thickness has been
documented in the coronary arteries, but not the cerebral vasculature [122]. Interestingly,
corrected rabbits demonstrate proximal thickening despite restoration of BP and WSS
similar to controls. These results indicate the possibility that altered vasorelaxation and
contractility of the SMC may occur in these arteries such that structural changes persist
after correction.
Comparing structural results to CFD indices in proximal arteries, it is possible
that the increased vascular remodeling in the proximal dAo of untreated CoA subjects
may be a result of significantly reduced TAWSS observed in this region which may
exacerbate structural changes due to increased BP [16]. Conversely, proximal corrected
arteries demonstrate significant vascular remodeling without any differences in TAWSS.
Comparing distal structural results with CFD indices, we observe a slight, but not
statistically significant, increase in vascular remodeling in the distal dAo of both CoA
and corrected rabbits which may be a result of significantly increased TAWSS in CoA
and reduced TAWSS in corrected rabbits in the distal dAo.
Although the exact cellular mechanisms governing these structural changes are
not know for the current rabbit model of CoA, structural changes may occur through
proliferation of smooth muscle cells [123], reduced apoptosis of smooth muscle cells, and
increased extracellular matrix deposition [106]. Previous research has identified several
vasoactive molecules involved in these processes, including platelet-derived growth
factor (PDGF), tissue growth factor (TGF-β), ANG II, and soluble heparin
glycosaminoglycans (HSPGs) [100, 124-126].
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It is likely that the structural changes of this aim correspond with alterations to
vascular biomechanics from PC-MRI strain results discussed in aim 1. For example,
reduced strain and distensibility were found in proximal arteries of untreated and
corrected rabbits, and this is coincident with vascular remodeling observed in the current
aim. Medial thickening and fragmentation of elastin in response to the coarctation may
cause alterations in the resting mechanical properties which are reflected in strain results.
Load induced fragmentation of elastin in particular has been linked with increased pulse
BP [36, 47, 127, 128], a hallmark of CoA. Alterations to conduit vessel stiffness serve to
compromise vascular compliance and contribute to permanent cardiovascular
complications [129-131].

Immunohistochemistry
Analysis of phenotypic smooth muscle modulation manifested by SM α-Actin,
NM myosin, SM MHC, and Caldesmon revealed increased NM myosin and decreased
SM MHC expression in untreated and corrected CoA in proximal regions, while SM αActin was unchanged. Phenotypic modulation occurring via decreased SM α-Actin has
been reported in several studies of hypertension and atherosclerosis [100]. However, few
of these studies to date have observed smooth muscle response in the large arteries and
previous work with animal models of CoA has demonstrated altered expression of
smooth muscle contractile proteins without significant depression of SM α-actin [105,
106]. It was further reasoned that medial smooth muscle may be multifunctional and that
loss of SM α-actin is not an absolute prerequisite for phenotypic changes. Previous work
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has shown NM myosin to have mechanosensitive properties that allow it to respond to
changes in mechanical stimuli through its expression and activation. Increased
application of cyclic strain reduces NM myosin expression [132], while more recent
studies demonstrate NM myosin activation to be increased in cell cultures with greater
rigidity [133, 134]. The mechanosensitive response of NM myosin is thought to involve
changes to its actin-linking and contractile functions, which subsequently affect smooth
muscle cell migration and adhesion. In the current study, mechanical stimuli in the form
of increased systolic BP, pulse BP, and increased mean BP appear to result in increased
NM myosin expression as well as decreased SM MHC expression. This dedifferentiation
may lead to medial thickening and elastin fragmentation at locations both near the site of
coarctation (proximal dAo) as well as further upstream (LCCA).
NM myosin and SM MHC dedifferentiation may cause proximal arterial
stiffening manifested through biomechanics indices of reduced distensibility and strain in
untreated and corrected CoA. Strain indices in the untreated group are likely due to the
downstream coarctation; however the findings of reduced strain and distensibility in the
corrected group indicates that passive mechanical properties are elevated despite BP
alleviation and is consistent with previous studies suggesting altered vascular properties
persist despite treatment [46]. Changes in passive mechanical properties are typically
reflected by alterations to collagen, elastin, and medial thickness [119], and aortic
stiffening causes increased cardiac afterload and decreased coronary perfusion [10, 135].
The current results indicate phenotypic changes in vascular SMC are present in these
regions, which may cause subsequent vascular remodeling and extracellular matrix
deposition resulting in arterial stiffening.
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Taken together, the stimuli of increased systolic, mean, and pulse BP appear to
provide a stimulus for structural alterations in coarctation in the form of increased medial
thickness and elastin fragmentation. Results from corrected rabbits suggest these
structural alterations take effect within 8-10 weeks of coarctation and persist upon BP
restoration. Vascular structural changes in untreated and corrected CoA may alter resting
mechanical properties of the conduit vasculature, and may thus elucidate the high rates of
early-onset coronary artery disease and hypertension suffered by post-repair CoA
patients. Preliminary immunohistochemistry results are the first to provide a possible
explanation involving SMC dedifferentiation by which surrogate endpoints for
cardiovascular disease are increased despite CoA correction, independent of genetic or
developmental factors. The increased expression of NM myosin and decreased SM MHC
expression in proximal regions of both untreated and treated groups may illustrate a
pathway wherein mechanical stimuli causes dedifferentiation of vascular SMC, which
results in medial thickening at the expense of aortic stiffening.

5.5 Limitations
Comparisons of structural alterations across groups must be interpreted within the
constraints of several potential limitations. As mentioned previously, changes in medial
thickness may occur through several different processes including increased SMC
proliferation, decreased SMC apoptosis, and increased extracellular matrix deposition.
The current methods sought to determine general structural changes present in untreated
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CoA and correction and thus do not allow observation of these specific phenomena,
leading to possible ambiguity in the exact cause of medial thickening. Previous research
using rabbit and pig models of CoA-induced hypertension have demonstrated an increase
in SMC proliferation that occurs in proximal arteries without a compensatory increase in
apoptosis [74, 106], thus supporting the role of a proliferative response to hypertension.
While the current results demonstrated elastin fragmentation, accurate evaluation of
changes to total elastin and collagen content will likely require implementation of
advanced molecular techniques targeting specific isoforms of these proteins [75, 136].
Indeed recent research with a rabbit model of CoA has demonstrated total collagen
expression is increased in the remodeling response to CoA, however the temporal and
spatial expression of collagen isoforms varied [75]. Future in vivo studies using 5-bromo2’-deoxyuridine (BrdU ), terminal deoxynucleotidyl transferase (TUNEL) labeling, and
collagen isoforms are feasible using the current methods [16, 74, 75], and may elucidate
the specific contributions of SMC proliferation and matrix deposition in observed medial
thickening.
While the use of Verhoeff Van Gieson’s staining uniquely allows observation of
elastic fibers, the specialized nature of the stain does not allow bulk staining of sections
and thus results in slight qualitative differences in color across individual samples. When
possible, these differences were corrected by appropriate white balancing and contrast
control using the IM50 software. This limitation was addressed by staining in small
groups to ensure proper differentiation occurred for all samples.

81

CHAPTER 6: QUANTIFY THE ENDOTHELIUM-DEPENDENT AND CONTRACTILE
RESPONSE TO AGENTS USING ESTABLISHED MYOGRAPH TECHNIQUES FOR
ARTERIAL SEGMENTS IN REGIONS OF ALTERED HEMODYNAMICS AND
VASCULAR BIOMECHANICS PROXIMAL AND DISTAL TO EXPERIMENTAL
COARCTATION AS COMPARED TO CONTROL RABBITS.

82
6.1 Review of rationale applicable to the current aim
The endothelium is dynamic, serving to sense mechanical stimuli and regulate
vasomotor tone by the release of dilatory substances, as well as antithrombotic and antiinflammatory agents to maintain vascular health [137, 138]. Impaired vasodilation
through endothelial NO release, assessed either through myograph studies in ex vivo
experiments or non-invasively through forearm hyperemic vasodilatory flow, is a
characteristic effect of hypertension. Furthermore, endothelial dysfunction has been
associated with numerous cardiovascular disorders including heart failure and
atherosclerosis, particularly in coronary artery disease [138, 139].
Vascular constriction, mediated by arterial smooth muscle, may also play a role in
the adaptive response of arteries to hypertension. Both active and resting components of
vascular contractility may contribute to stiffness. Resting stiffness is reflective of the
content of collagen, elastin, and medial thickness [119], while the active stiffness is a
function of vascular smooth muscle tone. Vascular stiffness is a risk factor for
cardiovascular disease and associated mortality [47, 140], and mounting evidence
suggests these vascular impairments caused by the interplay between altered
vasorelaxation and vasoconstriction may indicate increased risk of coronary artery
disease [17, 141].
CoA induces elevated mean, systolic, and pulse BP in the proximal arteries, and
these mechanical stimuli may directly affect vascular function in a manner that increases
the likelihood of adverse cardiovascular events. Currently the limited number and
heterogeneity of surgically repaired CoA subjects in clinical follow-ups has limited the
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interpretations of vascular function analysis. In addition, the in vivo assessment of
endothelial control of vascular tone in humans is constrained by several limitations and
assumptions which must be considered when interpreting clinical studies [141, 142].
Thus the objective of the current aim was to quantify the endothelium-dependent
relaxation and contractile response of proximal and distal dAo arteries in untreated and
corrected CoA using myograph techniques. Comparison of results across groups will
allow identification of possible functional abnormalities in spatial locations of interest in
the thoracic aorta and may elucidate substantial morbidities observed in human patients
following CoA repair.

6.2 METHODS

6.2.1 Harvest of arteries
The animal model for this specific aim has been described in detail in Specific
aim 1. Following BP catheter measurements and euthanasia described previously, arterial
segments from the descending thoracic aorta proximal and distal to CoA were excised
and maintained in cold (4º) physiological saline solution (PSS; in mM: 140 NaCl, 4.7
KCl, 1.2 MgSO4, 1.6 CaCl2, 1.2 NaHPO4, 2.0 MOPS adjusted to pH 7.4, 0.02
Na2ethylenediamine tetraacetic acid to chelate heavy metals, and 5.6 D-glucose).
Extreme care was taken to avoid damage to the fragile endothelium or smooth muscle
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tissue of the aorta upon removal. Arteries were harvested from the aorta at locations
illustrated in Figure 21, and were relatively far (>3 mm) from the CoA suture to avoid
any potential influence of surgical injury.

Figure 21. Diagram illustrating location of arteries harvested for histology (Hist),
immunohistochemistry (IHC), and myograph (Myo) experiments in the descending
thoracic aorta relative to the CoA and post-stenotic dilation (left). Example of map used
during harvest (right).

6.2.2 Aortic ring setup and preparation for myograph testing
Arteries were trimmed to 3-4 mm segments and removed of adhering tissue and
fat. The resulting segments were mounted on tungsten wire hooks (Figure 22) in a waterjacketed isometric myograph maintained in PSS at 37º C and bubbled continuously 95%
O2 5% CO2. Arteries were allowed to equilibrate for at least one hour in the bath at <2
grams resting tension as discussed in more detail below. To test the viability of tissue
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before experimentation, arteries were contracted using a potassium PSS (K+PSS) to
observe contractile response. K+PSS contains a relatively high concentration ([4.7] mM
in PSS vs. [109] mM in K+PSS) of potassium compared to PSS, which effectively
depolarizes the membrane and opens voltage dependent calcium channels, causing an
influx of extracellular calcium and subsequently contraction. Tissues were rinsed with
PSS at least 3 times following each activation, and allowed to return to resting force, and
this process was repeated 2-3 times until force response of an artery was consistent. The
time to peak arterial contraction was measured in order to observe general changes in
contraction due to calcium influx.

Figure 22. Example of rat thoracic aorta prepared for myograph analysis. Sample is
cleared of perivascular tissue, trimmed to 3-4 mm width with squared ends, and mounted
on isometric force transducer. (Danish Myo Technology product systems [5])

86
6.2.3 Determination of resting force
Previous experiments investigating the force-length relationship of smooth muscle
have identified a broad peak under which resting lengths produce maximum force due to
optimum interaction of actin and myosin filaments (Figure 23), reasoned to be the
functional length at which smooth muscle operates under resting physiology.

Figure 23. Schematic diagram of smooth muscle length-tension curve. Myosin-actin
filament interactions associated with respective lengths are shown to illustrate changes
in tension development. At “functional length”, myosin and actin filaments interact
optimally, resulting in peak tension development. (Adapted from Marieb et al, [6])

Subsequent studies investigated the range of functional length in airway smooth
muscle and demonstrated functional length occurred when resting force was 10-20% of
active force [143-145]. At lengths corresponding to <10% resting force, active contractile
force is decreased and the smooth muscle undergoes visible extension. At lengths >10%,
active force is decreased as the smooth muscle resists stretch. Together these studies
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illustrate a reproducible reference length for smooth muscle which is important when
studying the physical properties of vasomotor tone.
In order to determine the appropriate resting force for functional length in the
current study, preliminary experiments with this model investigated active/resting force
ratios from K+PSS contractions under resting forces from 1-5g with control rabbits. It
was found that 2 g resting force most consistently produced an active/resting force ratio
of 10-20%, and therefore this functional force of 2g was for used for all myograph
experiments. This resting force is in agreement with additional studies [146, 147]
investigating the functional response of rabbit aortic rings. The decision to use a uniform
resting force for all subjects based on control subjects is further discussed in Limitations.

6.2.4 Endothelial relaxation: Acetylcholine
To determine the effect of CoA-induced BP and hemodynamic alterations on
endothelial function, aortic rings were first pre-contracted with 0.2 uM Phenylephrine
(PE) and endothelium-dependent NO relaxation was determined by cumulative addition
of acetylcholine (ACH, 10-9 to 10-5 M) (Figure 24). Force measurements were obtained 5
minutes after addition of ACH, and cumulative response curves were constructed as
percentages of active relaxation from pre-contracted tension.
Acetylcholine is an agonist of the M3 muscarinic receptor which has been used
extensively to measure the release of NO from the intact endothelium and cause
vasodilatation [148, 149]. Activation of the M3 receptors on endothelial cells causes an
increase in nitric oxide synthase activity, which results in an increased synthesis of the
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highly diffusible free radical NO. NO diffuses from the endothelial cells into the adjacent
smooth muscle of the vascular media, where it activates the cytoplasmic enzyme
guanylate cyclase. This increases intracellular cyclic-3’-5’-guanosine monophosphate
(cyclic GMP or cGMP) which activates cGMP protein kinase and promotes relaxation of
the SMC by reduction of cytosolic Ca2+ concentration. As this process is critically
dependent on the presence of an intact endothelium, the relaxation response to ACH
provides an accurate estimate of endothelial function.

Figure 24. CHART data of Acetylcholine relaxation from myograph experiments with arteries
from proximal (blue trace) and distal (green) regions displayed. Arrows indicate when ACH was
administered to baths. Subsequent release of NO from the endothelium results in smooth muscle
relaxation and decreased force.
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6.2.5 Endothelium-independent relaxation: Sodium Nitroprusside
Following ACH experiments, samples were washed at least three times with fresh
PSS and equilibrated for >1 hour prior to determining endothelium-independent
vasorelaxation to cumulative doses of Sodium Nitroprusside (SNP; a NO donor, 10-9 to
10-5 M) (Figure 25). Samples were again pre-contracted with 0.2 uM PE before SNP
relaxation, and SNP response curves were constructed as percentages of active relaxation
from pre-contracted tension.
SNP metabolizes in PSS to release NO, which diffuses to the vascular smooth
muscle, causing cGMP-mediated relaxation. As an NO donor, SNP is not dependent on
the presence of endothelial cells to cause relaxation and thus provides a method to
observe if vasorelaxation impairments are specific to the endothelium.
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Figure 25. CHART data of Sodium Nitroprusside relaxation from myograph experiments with
arteries from proximal (blue trace) and distal (green) regions displayed. Arrows indicate when
SNP dose was administered to baths. SNP metabolizes to release NO, resulting in smooth muscle
relaxation and decreased force independent of the endothelium.

6.2.6 Vascular contractility
Following SNP relaxation experiments, samples were rinsed at least 3 times with
PSS and allowed to equilibrate for at least one hour at resting force. Aortic rings were
then stimulated with cumulative concentrations of PE (10-9 to 10-5 M) (Figure 26).
Effective force response to each PE concentration was normalized to the tissue’s
maximum K+PSS contractile response to account for potential differences in size and
cross-sectional area. Cumulative dose response curves for PE were constructed for each
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group. Phenylephrine is an agonist of the α1-adrenergic receptor which causes activation
of ionosol-triphosphate (IP3) and subsequently calcium release from the sarcoplasmic
reticulum leading to vasoconstriction.

Figure 26. CHART data of Phenylephrine contraction from myograph experiments with arteries
from proximal (blue trace) and distal (green) regions displayed. Arrows indicate when PE dose
was administered to baths. PE activates IP3, resulting in the release of calcium from the
sarcoplasmic reticulum and thus contraction, which increases force.

6.2.7 Statistical procedures used for data analysis
4-5 rabbits were used for each experimental group. At least 2 arterial sections
from each spatial location of interest was taken for each rabbit from which measurements
were averaged to obtain an estimate of effective dose response values for each subject.
Representative CRC curves were obtained by averaging the spatial locations in a single
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group of rabbits. Statistical analysis of myograph data was conducted as detailed in the
methods common to all specific aims.

6.3 RESULTS

6.3.1 Endothelial relaxation
Arterial relaxation curves in response to the endothelium-dependent agonist ACH
at proximal and distal locations are shown in Figure 27. Proximal to the coarctation,
control rabbits show intact endothelial function by demonstrating ACH relaxation to
~80% of pre-contracted tension. In contrast, both CoA and corrected rabbits showed
significantly impaired ACH relaxation (17% ± 4% and 33% ± 6% respectively, P<0.05),
with CoA rabbits showing marked impairment at peak ACH values. In the distal region,
differences between corrected and controls were abolished with endothelial function
intact in these groups and relaxations of 85% ± 3% and 78% ± 3% respectively. CoA
rabbits continued to show significantly impaired ACH relaxation (P<0.05) with peak
relaxation of 18% ± 8% of pre-contracted tension.
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Figure 27. Active vasorelaxation curves in response to ACh for rings of aortic tissue
proximal (top) and distal (bottom to the coarctation region in CoA and corrected groups
as compared to spatially equivalent locations from control rabbits.  = CoA significantly
different (P<0.05) from control;  = corrected significantly different (P<0.05) from
control; § = CoA significantly different (P<0.05) from corrected.

Endothelium-independent relaxation to the agonist SNP (Figure 28) in the
proximal dAo reached ~90% of pre-contracted values in control rabbits. Significant
differences between CoA and controls were present at lower doses of SNP (log [-7.5 to 6.5]), however peak SNP relaxation between all groups was not significantly different.
Interestingly, corrected rabbits showed similar SNP relaxation response at all doses
compared to controls. In the distal dAo, corrected and control rabbits continued to show
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similar SNP relaxation response, while CoA rabbits had significantly greater relaxation
compared to corrected group at early doses (log[-7 to -4.5]), and control group at peak
doses (98% ± 1% in CoA vs 90% ± 1% in controls).

Figure 28. Active vasorelaxation curves in response to SNP for rings of aortic tissue
proximal (top) and distal (bottom to the coarctation region in CoA and corrected groups
as compared to spatially equivalent locations from control rabbits.  = CoA significantly
different (P<0.05) from control;  = corrected significantly different (P<0.05) from
control; § = CoA significantly different (P<0.05) from corrected.
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6.3.2 Vascular contractility
PE force response was evaluated at proximal and distal dAo locations (Figure
29). In the proximal aorta control rabbits show normalized effective force response
peaking at 1.13 ± 0.08, while both CoA and corrected groups showed significantly
diminished force at several concentrations of PE, peaking at 0.94 ± 0.04 and 0.92 ± 0.03
respectively (P<0.05). In the distal dAo, control rabbits demonstrated peak contractility
of 1.04 ± 0.05 and CoA force response was similar, albeit slightly increased. Interestingly
corrected force response remained significantly reduced (P<0.05) compared to controls
with peak isometric force of 0.88 ± 0.06.
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Figure 29. Active contraction curves in response to PE for rings of aortic tissue proximal
(top) and distal (bottom to the coarctation region in CoA and corrected groups as
compared to spatially equivalent locations from control rabbits.  = CoA significantly
different (P<0.05) from control;  = corrected significantly different (P<0.05) from
control; § = CoA significantly different (P<0.05) from corrected.

6.3.3 Time to peak contraction
Time to peak contractile response of K+PSS quantified from arteries proximal and
distal to CoA is displayed in Figure 30. In proximal arteries, untreated CoA samples
demonstrated significantly increased time to reach peak contraction. Time to peak
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contraction in arteries of corrected CoA rabbits in this region were slightly increased, but
did not reach significance. Differences between groups were abolished distal to CoA.

Figure 30. Time to peak K+PSS contraction in respective experimental groups in dAo
arteries proximal and distal to CoA. Values are presented ± SEM,  = CoA significantly
different (P<0.05) from control.

6.4 SUMMARY
The myograph techniques applied to the animal model used for the current
investigation illustrates a method for quantifying endothelial and contractile function of
the aortic vasculature in response to untreated and corrected CoA. While previous
research has identified impaired endothelial relaxation and altered contractility to occur
in response to acute hypertension and vascular injury of conduit arteries [95, 150], the
specific effects of CoA and correction have not been investigated to date in a clinically
representative model. The current aim provides a reproducible method of analysis by
which changes to endothelial function as well as resting and active force can be observed
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following CoA and correction representative of surgical treatment at spatial locations
where hemodynamic and vascular biomechanics indices can be determined.

Endothelial dysfunction
Proximal dAo arteries from untreated and corrected experimental groups
demonstrate endothelial dysfunction as ACh relaxation response from both groups
showed significant impairments while peak SNP relaxation response (endotheliumindependent) was unchanged. These results suggest a reduced NO bioavailability present
in both untreated and corrected groups in the proximal arteries, possibly due to the
damaging effects of elevated SBP and pulse BP. Distal arteries of the CoA group
continued to show endothelial dysfunction, while no differences between corrected and
controls were present. Importantly peak ACH relaxation in CoA and corrected groups
ranged from 10-20%, and previous research using similar myograph methods consider
ACH relaxation less than 50% to be non-functional [151]. While endothelial dysfunction
in proximal arteries of untreated CoA rabbits is in agreement with spontaneously
hypertensive animal models [95], the data presented from corrected rabbits is the first to
demonstrate endothelial dysfunction in coarctation despite complete BP alleviation.
These results are consistent with recent clinical evaluations of normotensive post-repair
patients who demonstrate reduced forearm vasodilation during reactive hyperemia
compared to age-matched control patients [65, 70]. Atherosclerosis, particularly in
coronary artery disease, is associated with endothelial dysfunction as a result of reduced
endothelial NO release, and indeed high rates of early-onset coronary artery disease are a
primary form of morbidity leading to reduced life expectancy in surgically treated CoA
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[9, 27]. Whether the etiology of endothelial dysfunction observed here is a result of
reactive oxygen species or increased expression of inflammatory and/or adhesion
molecules is currently unclear. Previous studies investigating NO bioavailability in aortabanded hypertensive animal models report evidence of increased expression of reactive
oxygen species in proximal arteries and unchanged expression in regions distally [97,
152, 153]. While a considerable difference was present in terms of BP gradients used
(~20 mmHg in current study vs. 75-100 mmHg in cited studies) these studies may
suggest a possible explanation for reduced NO availability in untreated and corrected
CoA which leads to the substantial late morbidities observed.
The finding of endothelial impairment in distal arteries of CoA rabbits may be
attributable to the presence of high velocity and WSS in these regions. Previous research
demonstrated remodeling and fragmentation of the IEL to occur under significantly
increased blood flow rates [154]. Thus sustained conditions of increased flow in the
untreated CoA group due to the stentoic velocity jet may serve to alter the endothelial
environment and subsequently NO release. IEL fragmentation due to high WSS may also
explain the slight increase in distal dAo SNP relaxation response at several
concentrations, as NO may diffuse more readily into medial smooth muscle to cause
relaxation.
The possible influence of structural alterations to endothelial dysfunction must be
considered as well. Vascular remodeling is evident in the form of fragmented elastin and
increased medial thickness in CoA and corrected proximal arteries, and these changes
may conceivably cause increased NO diffusion distance and altered NO relaxation of
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SMC. However, since CoA and corrected rabbits demonstrate peak SNP relaxation
similar to controls it is unlikely that structural changes affect SMC relaxation to NO.

Altered vascular contractility
Myograph results demonstrated reduced active tone through diminished PE force
response in proximal arteries of both untreated and corrected rabbits. These findings are
likely a direct consequence of the increased passive stiffness illustrated in these regions
in Aim 1. In order to maintain the vessel diameter, previous work with hypertensive rat
arterioles illustrated that increasing passive force decreases the capacity for active force
response [45]. Although studied less frequently than resistance vessels, conduit arteries
demonstrate an ability to adapt smooth muscle tone in response to WSS and BP to control
luminal diameter [17]. In both untreated and corrected CoA, elevated BP due to the
stenosis causes alterations to vessel stiffness and vascular medial thickness. It is possible
that if vascular remodeling increases resting force in response to CoA-induced
mechanical stimuli, active force of proximal aortas in untreated and treated groups must
be limited to avoid excessive vasoconstriction and narrowing of the lumen. Furthermore,
since maximum active force in the untreated and corrected groups was reduced compared
to control, it is likely that active force is a consequence of aortic stiffness and not a
contributing factor.
Reduced active force observed in distal arteries of corrected rabbits occurred
without transient increase in BP and is thus not strictly consistent with proximal results.
The presence of significantly reduced TAWSS in corrected rabbits at this region from
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CFD results may explain reduced tension, as alterations in WSS may affect smooth
muscle contractility (discussed in limitations).

Results from time to peak contraction K+PSS measurements revealed untreated
CoA had significantly longer contraction times in the proximal region, while no
differences were present in the distal region. K+PSS causes contraction through two
mechanisms. The primary mechanism is thought to occur by the depolarization of smooth
muscle membrane by K+, which causes the opening of voltage-dependent channels and
thus an influx of calcium, while a secondary mechanism of calcium sensitization through
translocation of RhoKinase may play a minor role in contraction as well [155]. It is
possible that structural changes in the form of increased medial thickness in proximal
untreated CoA (and to a minor extent corrected CoA) may increase diffusion distance for
calcium, thus increasing the time to peak contraction. Changes in cytoskeletal proteins
may result in altered resting mechanical properties which affect contractile force response
time, as increased stiffness should result in reduced time to peak contraction. However
the opposite trend is observed in the current results, as proximal untreated CoA arteries
showed significantly increased stiffness. Thus it is likely that cytoskeletal alterations to
passive mechanical properties can be ruled out as a cause of increased time to peak
contraction. Lastly, it is possible that changes in second messenger pathways including
IP3 and PKC may be altered in CoA pathology such that calcium transport is affected
[156, 157]. However, without parallel observation of contraction time with appropriate
inhibitors to calcium-dependent pathways and measurement of transient calcium currents,
second messenger changes cannot be confirmed.
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6.5 Limitations
While the current methods allow comparison of functional properties in CoA,
results should be considered against several potential limitations. Perhaps the most
significant is the use of a uniform resting force for all groups. Arteries are thought to
operate at a consistent functional length, discussed previously in methods. Preliminary
experiments identified a resting force of 2g to be an appropriate resting length in control
rabbits; however it is conceivable that structural and functional changes are present in
untreated and corrected CoA rabbits which may result in an altered functional length and
thus resting force in these groups. It was reasoned that making consistent comparisons
across groups was of greater importance than using a variable resting force for each
group after review of literature using myograph analysis in pathophysiological states [95,
150, 158] and discussions with an expert researcher in this area [146, 159] (Dr. Katherine
Gauthier, personal communication).
Differences in active force observed across groups are thought to be a result of
changes in resting and active components of smooth muscle contraction, independent of
intracellular calcium regulation. However, it is conceivable that observations may be a
result of calcium-dependent pathways including cGMP kinase and L-type channels, or
calcium-independent G-protein coupling, all of which serve to alter contractility in
response to sustained hemodynamic stimuli through shear stress [38, 39, 160, 161].
Future studies using inhibitors for calcium channels (Verapamil) and agonist activation
(Phentolamine) are feasible using the current methods and will allow the determination of
calcium-dependent regulation in contractile force response in untreated and corrected
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CoA. Several studies have indicated mechanisms by which contractile response is
calcium-independent [39, 147], identifying the Rho kinase pathway as being primarily
responsible for this phenomenon, with protein kinase C (PKC) involved to a lesser degree
[38, 160]. To obviate this limitation, future models in vivo models will analyze peak
contractile response to KPSS and Phe before and after incubation with Y-6732, a highly
specific Rho-kinase inhibitor to determine what role if any calcium sensitization plays.
Preliminary experiments with the current rabbit model have shown the maximum
effective relaxation of healthy controls to ACH is approximately 80%. A review of
studies investigating endothelial relaxation in the thoracic aorta routinely reveals +90%
relaxation of pre-contracted force [146, 159]. These studies further demonstrated a
decrease in endothelial relaxation to occur with increasing age. Therefore this limitation
may be attributable to the 32-week timeline of rabbits used in the present study, as
compared to the 4-8 week animal models used in previous studies. Since the objective of
the current aim was to quantify endothelial relaxation across untreated and corrected
groups and timelines were identical across groups, this limitation is not likely to influence
conclusions.
While changes in active force were quantified across groups, it is possible that
evaluation of vascular tension, defined as pressure*radius, may be more pertinent to
physiological vascular function. The current experiment did not facilitate the use of a
controlled pressure-diameter setup which may allow evaluation of passive and active
tension in situ.
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CHAPTER 7: FUTURE DIRECTIONS AND CONCLUSIONS
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7.1 Review of investigation findings
The work presented has provided unique insight into the consequences of CoA
and correction that consider hemodynamic, structural, and functional changes caused by
the disease. Collectively, results provide evidence that the ramifications of coarctation go
beyond removal of the stenosis and restoration of the pressure gradient. The unique
contributions this work has made to the field are as follows and summarized in a
simplified table to display significant differences (Table 5):
1) Subject specific CFD simulations using an established animal model of CoA
and correction consistent with BP gradient endpoint criteria of CoA
intervention in humans, as well as morphological outcomes in agreement with
previous imaging studies, revealed significant hemodynamic alterations in the
form of reduced TAWSS in proximal arteries and markedly increased
TAWSS in the distal aorta of untreated CoA subjects. Distal alterations to
hemodynamics may be particularly important as corrected subjects
demonstrated reduced TAWSS persists despite BP restoration. Increased
stiffening in the proximal arteries of both untreated and corrected CoA
subjects was demonstrated through analysis of vascular biomechanics
quantified from CFD simulations. These findings suggest altered
hemodynamics and vascular biomechanics in untreated and corrected CoA
may influence any structural and functional changes present in these groups.
2) Structural changes in the form of increased medial thickness and elastin
fragmentation were found to occur in the proximal arteries of untreated CoA
through histological analysis. These changes persist in the corrected group,
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suggesting mechanisms of medial thickening occur before correction at 8-10
weeks and are not restored with alleviation of BP.
3) Analysis of smooth muscle differentiation protein expression demonstrated
significantly increased NM myosin expression and decreased SM MHC
expression in proximal arteries of both untreated and corrected CoA. This
dedifferentiation may influence vascular biomechanics indices of reduced
strain and distensibility observed.
4) Impaired ACh relaxation occurred in the proximal arteries of both untreated
and corrected groups while SNP relaxation was >90%, indicating endothelial
dysfunction occurs in untreated CoA and persists with correction. In addition,
reduced active force was present in untreated and corrected groups, likely due
to the elevated passive stiffness in these arteries.

Table 6. Summary of significant changes to measured parameters compared to controls.
↑ = significant increase (↑↑ marked increase); ↓ = significant decrease (↓↓ marked
decrease); NC = No significant differences; N/A = Measurement not available.
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CoA causes increased BP and tensile stress as well as reduced TAWSS in
proximal arteries which results in SMC phenotypic changes evidenced by NM myosin
and SM MHC. This dedifferentiation results in increased medial thickness and increased
stiffness, which reduces the need for active force response. Furthermore, the increased
tensile stress and reduced TAWSS causes proximal endothelial dysfunction in CoA.
Distally TAWSS is markedly increased by the stenotic velocity jet, which causes
endothelial dysfunction and increased SMC (endothelium-independent) relaxation.
These results are somewhat in agreement with work by [154] who presents evidence that
high WSS results in fragmentation and disruptions of the IEL which may explain loss of
mechanical properties.
Despite no change in BP or TAWSS in the proximal arteries of corrected rabbits,
dedifferentiation persists and continues to cause increased medial thickness and increased
stiffness, reducing the need for active force response. Endothelial dysfunction persists in
proximal corrected arteries and is thus established within 8-10 weeks of CoA. Distally the
residual dilatation present in corrected aorta results in reduced TAWSS which causes a
reduced active force response.

7.2 Future Directions
The findings in the presented research lend themselves to various applications in
biomedical engineering and medicine directed at future research and treatment techniques
of congenital CoA. These may include the identification of cellular mechanisms present
in the CoA pathology and the development of exercise therapies for CoA patients.
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Cellular mechanisms
Global changes in structure and function have been identified due to CoA and
correction; however the development of novel interventions may require identification of
specific cellular mechanisms which result in changes to medial thickness and vascular
function. Research utilizing animal models of hypertension and flow ligation have
identified possible mechanistic pathways to these stimuli, with TGF-β, fibronectin,
heparin sulfate glycosaminoglycans (HSPGs), and matrix metalloproteases (MMPs) all
suggested to play considerable roles in the vascular remodeling and functional response
[36, 74, 103, 126, 130, 162-164]. These mechanisms may be similarly involved in CoA in
a manner that explains structural and functional changes, and the current research for the
first time provides a reproducible model to investigate these phenomena in the
pathophysiology of untreated and corrected CoA. Successful identification of pathways
leading to long term morbidities in CoA may allow application of inhibitors to augment
surgical treatment and thus improve patient outcomes of life expectancy.

Exercise Therapies
The current research demonstrates evidence of altered endothelial function
occurring due to CoA and persistent upon correction. Normal endothelial function is
integral to vascular health due to the production of numerous vasodilators, antiinflammatory, and antithrombotic agents. Impaired NO availability and relaxation is
associated with numerous negative cardiovascular outcomes as previously discussed.
Interestingly, recent research suggests that if the endothelium is activated during exercise,
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it can be postulated that repetitive exposure to exercise induced hemodynamic and WSS
changes may result in adaptation such that the NO dilatory function is up-regulated.
Indeed, regular exercise training is associated with increased vasodilator capacity and
longitudinal studies suggest an anti-atherogenic effect with regular activity [37, 165,
166]. The current research uniquely identifies persistent endothelial dysfunction to occur
in proximal arteries despite CoA correction, and thus suggests a potential benefit for the
development of simple exercises, such as an isometric hand-grip routine, to augment
post-surgical treatment. Children with CoA are generally discouraged from exercise due
to the potential negative effects from the increase in BP during the exercise itself.
However, development of these relatively light exercise regiments would serve to
increase endothelial stimulation of the proximal arteries and thus may improve
endothelial function in a manner that counteracts negative changes due to CoA.
Additionally, exercise treatments may mitigate the need for extended drug therapies for
these patients, which is of particular benefit when considering the young age of patients
undergoing surgical CoA treatment.

7.3 Conclusions
The present results demonstrate that untreated and corrected CoA result in
alterations to hemodynamics, vascular structure, and vascular function that occur
independent of genetic or developmental factors. Untreated CoA causes significant
alterations to TAWSS in the proximal and distal thoracic aorta, and these changes persist
in the distal region despite correction of CoA and alleviation of BP. Medial thickening
and increased passive stiffness occur in the proximal arteries of both untreated and
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corrected CoA. In addition, the functional properties of untreated and corrected CoA
subjects are significantly disturbed as endothelial dysfunction and reduced active tension
is present in both groups. The animal model creates a platform to accurately replicate
untreated CoA and surgical correction through resection and end-to-end anastomosis for
the first time, while the use of a coupled imaging and experimental technique allows
unique localization of hemodynamic and vascular biomechanics alterations and parallel
observation of structural and functional changes which may have direct consequences on
cardiovascular health. In addition to providing a unique insight of CoA pathology to
clinicians, the current methods may facilitate the identification of specific cellular
mechanisms leading to late morbidities, which may lead to targeted inhibitors as
therapeutic agents.
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